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Abstract An inverse relationship exists between striated
muscle ﬁber size and its oxidative capacity. This relation-
ship implies that muscle ﬁbers, which are triggered to
simultaneously increase their mass/strength (hypertrophy)
and fatigue resistance (oxidative capacity), increase these
properties (strength or fatigue resistance) to a lesser extent
compared to ﬁbers increasing either of these alone. Muscle
ﬁber size and oxidative capacity are determined by the
balance between myoﬁbrillar protein synthesis, mitochon-
drial biosynthesis and degradation. New experimental data
and an inventory of critical stimuli and state of activation
of the signaling pathways involved in regulating contractile
and metabolic protein turnover reveal: (1) higher capacity
for protein synthesis in high compared to low oxidative
ﬁbers; (2) competition between signaling pathways for
synthesis of myoﬁbrillar proteins and proteins associated
with oxidative metabolism; i.e., increased mitochondrial
biogenesis via AMP-activated protein kinase attenuates the
rate of protein synthesis; (3) relatively higher expression
levels of E3-ligases and proteasome-mediated protein
degradation in high oxidative ﬁbers. These observations
could explain the ﬁber type–ﬁber size paradox that despite
the high capacity for protein synthesis in high oxidative
ﬁbers, these ﬁbers remain relatively small. However, it
remains challenging to understand the mechanisms by
which contractile activity, mechanical loading, cellular
energy status and cellular oxygen tension affect regulation
of ﬁber size. Therefore, one needs to know the relative
contribution of the signaling pathways to protein turnover
in high and low oxidative ﬁbers. The outcome and ideas
presented are relevant to optimizing treatment and training
in the ﬁelds of sports, cardiology, oncology, pulmonology
and rehabilitation medicine.
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ADP Adenosine diphosphate
AMP Adenosine monophosphate
AMPK AMP-activated protein kinase
ATP Adenosine triphosphate
bFGF Basic ﬁbroblast growth factor
CaMK Calcium/calmodulin protein kinase
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FAK Focal adhesion kinase
FOXO Forkhead box transcription factors O
GAPDH Glyceralde-3 phosphate dehydrogenase.
GSK-3b Glycogen synthase kinase-3b
HGF Hepatocyte growth factor
HIF-1a Hypoxia-inducible factor-1a
IGF-I Insulin-like growth factor-I
IGFBP Insulin-like growth factor binding protein
IGF-IR Insulin-like growth factor receptor
IL Interleukin
IRS-2 Insulin receptor substrate-2
JNK c-Jun N-terminal kinase
MAFbx Muscle atrophy F-box
MAPK Mitogen-activated protein kinase
MEF-2 Myocyte enhancer factor-2
MGF Mechano-growth factor
miRNA Micro RNA
mRNA Messenger RNA
mtDNA Mitochondrial DNA
mtmRNA Mitochondrial mRNA
mTOR Mammalian target of rapamycin
mtrRNA Mitochondrial rRNA
MuRF Muscle ring ﬁnger
MyHC Myosin heavy chain
nDNA Nuclear DNA
NF-jB Nuclear factor kappa-B
NFAT Nuclear factor of activated T cells
nNOS Neuronal nitric oxide synthase
NO Nitric oxide
NOS Nitric oxide synthase
PGC-1a Peroxisome proliferator-activated receptor c
co-activator 1a
p38 38 kDa stress-activated protein kinase
p70S6K 70-kDa ribosomal protein S6 kinase
PA Phosphatidic acid
PCR Polymerase chain reaction
Pi Intracellular phosphate
PI3K Phosphatidylinositol 3-kinase
PLD Phospholipase D
PO2 Interstitial oxygen tension
RNS Reactive nitrogen species
ROS Reactive oxygen species
rRNA Ribosomal RNA
SAC Stretch-activated channel
SDH Succinate dehydrogenase
SRF Serum response factor
TGF-b Transforming growth factor-b
TNF-a Tumor necrosis factor-a
tRNA Transfer RNA
TSC-2 Tuberous sclerosis complex-2
VEGF Vascular endothelial growth factor
VO2max Maximum rate of oxygen consumption
Vps34 Vacuolar protein sorting mutant 34
Introduction
Three decades ago, it was ﬁrst demonstrated in humans that
training at the same time for both strength and endurance
results in less adaptation of skeletal muscles compared
to training for either one alone, a phenomenon known as
the concurrent training effect (Hickson 1980). Generally,
resistance exercise leads to an increase in muscle mass
(hypertrophy), whereas endurance exercise is associated
with increased oxidative metabolism (mitochondrial and
capillary density, oxidative enzymes) and no hypertrophy.
Why do muscles have limited capacity to increase strength
(i.e., ﬁber size) and endurance capacity (i.e., oxidative
metabolism) at the same time? To clarify the relationship
between the regulation of ﬁber size and oxidative metab-
olism, the present review will focus on the potential cel-
lular and molecular mechanisms underlying the size
differences in high and low oxidative muscle ﬁbers. The
results and concepts presented in this review are not only
relevant to cell and molecular biologists with interest in
muscle physiology, but also to the ﬁelds of sports and
rehabilitation medicine where they are important for
understanding physiological limitations in performance
(e.g., in patients suffering from chronic diseases) and
can be helpful in developing strategies to improve
performance.
Virtually, all vertebrate body movements are generated
by coordinated activity of skeletal muscles with varying
contractile properties, which are governed by the muscle
phenotype. Muscle phenotype is the result of interaction
between genotype and external inﬂuences on muscle ﬁbers
and is largely deﬁned by the number of muscle ﬁbers, the
ﬁber cross-sectional area, the number of sarcomeres in
series, the muscle ﬁber type distribution and muscle
architecture. Muscle ﬁber types are generally distinguished
according to the predominantly expressed isoform of
myosin heavy chain (MyHC), which are referred to as type
I, IIA, IIX and IIB. Muscle ﬁbers have the ability to adapt
their phenotype and modify MyHC-type, architecture and
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123their size in response to changes in internal or external
environment (Pette and Staron 2001).
The maximum rates of oxygen consumption (VO2max)
per volume unit and the cross-sectional areas of striated
myocytes from different vertebrates vary over a 100-fold
range. Muscle ﬁbers with a high oxidative capacity are
relatively small compared to ﬁbers with a low oxidative
capacity (Van Der Laarse et al. 1998), pointing to an
inverse relationship between ﬁber cross-sectional area and
VO2max (Fig. 1). A Hill-type model for oxygen diffusion
(Hill 1965) predicts that the maximum value of the prod-
uct, cross-sectional area 9 oxygen consumption, is limited
by the extracellular oxygen tension as given by:
CSA VO2max 4pa MDO2 PO2;
where VO2max is the maximum rate of oxygen consumption
in (nmol mm
-3 s
-1), CSA is the cross-sectional area of the
myocyte (in mm
2), aM is the solubility of oxygen in muscle
(in mM mmHg
-1), DO2 is the diffusion coefﬁcient for
oxygen in sarcoplasm (in mm
2 s
-1), and PO2 (in mmHg)
equals the interstitial oxygen tension. If the value of the
left-hand term of the equation is larger than that of the
right-hand term, an anoxic core in the muscle cell will
develop when the cell is maximally activated, causing a
reduction in the rate of oxidative ATP production. Thus,
any increase in either CSA or VO2max (or both) would
require a proportional increase in extracellular PO2 above
the value at which the core of the cell becomes anoxic at
the maximum rate of oxygen consumption (PO2crit).
Experimental determination of aM 9 DO2 (Krogh’s diffu-
sion coefﬁcient) at VO2max (van der Laarse et al. 2005)
validated the Hill model and allowed estimating that stri-
ated muscle cells are evolved to function at their maximum
rate of oxygen consumption at an extracellular PO2 of
about 14 mmHg.
It is worth noting that, on one hand, VO2max is pro-
portional to succinate dehydrogenase (SDH) activity
(Bekedam et al. 2003; Des Tombe et al. 2002; van der
Laarse et al. 1989) or oxoglutarate dehydrogenase activity
(Blomstrand et al. 1997) and consequently to the number of
mitochondria (Hoppeler and Billeter 1991; Reichmann
et al. 1991), while several studies consistently showed that
muscle ﬁbers with a relatively large cross-sectional area
had low SDH activities and vice versa (e.g., Kayar and
Banchero 1987; Rivero et al. 1999; Smith and Ovalle
1973). These last results, however, are not normalized for
optical density per time unit, ﬁber volume and physiolog-
ical temperature.
The relationship between cross-sectional area and
mitochondrial density implies that a muscle ﬁber can
hypertrophy (and become stronger) at the expense of its
maximum steady state power per ﬁber volume (i.e.,
endurance capacity). To prevent a decline in maximum
steady state power, oxygen supply to the mitochondria
should be improved, for instance by:
1. increasing oxygen transport to the muscle ﬁber, e.g.,
by increasing myoglobin, capillary density, hematocrit
or a combination of these (Des Tombe et al. 2002;
Hickson and Rosenkoetter 1981; van Beek-Harmsen
et al. 2004)
2. reducing the diffusion distance for oxygen to the
mitochondria by relocating the mitochondria to the
sarcolemma (Deveci et al. 2001; Hardy et al. 2009).
However, this would imply large radial gradients of
(phosphoryl)creatine, Pi and DGATP, which can be
expected to have functional consequences.
Although it may be feasible to increase mitochondrial
density while ﬁber size remains similar or even increases,
these adaptations are associated with an increase in the
number of capillaries per ﬁber, hence increase in capacity
for oxygen supply (Bigard et al. 1991; Desplanches et al.
1996; Deveci et al. 2001; Green et al. 1999). However, to
be able to extract oxygen from the blood and to prevent an
Fig. 1 Maximum rate of oxygen consumption (VO2max in
nmol mm
-3 s
-1) of muscle preparations at physiological temperature
from various species plotted against the cross-sectional area (in lm
2)
of the muscle cells in the preparation. A hyperbola was ﬁtted through
all data points. The ﬁt hardly deviates from the Hill-type diffusion
model shown in the text and is described by the function
VO2max = constant CSA
-1. The value of the constant is calculated
as the mean of the products VO2max and CSA for each muscle ﬁber
type and approximates 0.4 pmol mm
-1 s
-1. Inset cross sections
stained for succinate dehydrogenase activity. From left to right: right
ventricular wall of normal rat myocardium, rat extensor digitorum
longus muscle, human vastus lateralis muscle, ilioﬁbularis muscle of
Xenopus laevis; scale bar 100 lm. ratMCT right ventricular rat
cardiomyocytes of a monocrotaline-induced pulmonary hypertensive
rat, humanCHF vastus lateralis muscle of human chronic heart failure
patients. Figure adapted from (Bekedam et al. 2003; Van Der Laarse
et al. 1998)
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123anoxic core, PO2crit of muscle ﬁbers must be lower than
end capillary PO2, which equals 15–20 mmHg in exercis-
ing humans (Calbet et al. 2009). This is close to the cal-
culated PO2crit. Increasing PO2crit to a value approaching
end capillary PO2 would require an exponential increase in
the number of capillaries per muscle ﬁber to prevent hyp-
oxic cores, which, to the best of our knowledge, has not
been reported. Therefore, the smaller size of high oxidative
muscle ﬁbers can be considered an evolutionary design
constraint.
It should be realized that the classiﬁcation of types
based on MyHC (I, IIA, IIX and IIB) does not necessarily
correlate with the oxidative capacity of the muscle ﬁber.
In general, type IIB/IIX ﬁbers have a relatively low oxi-
dative capacity and a large ﬁber size compared to type I
ﬁbers. However, when comparing the oxidative capacity
and ﬁber size between type IIA and type I ﬁbers, litera-
ture shows less distinctive results. For example in men, it
appears that type I ﬁbers have relatively small CSA
compared to type IIA ﬁbers (*5,000 vs. *7,000 lm
2),
while their oxidative capacity (as determined by SDH) is
signiﬁcantly higher (Gregory et al. 2001). Also, Bekedam
et al. (2003) showed that human type I ﬁbers showed
smaller CSA and signiﬁcantly higher SDH activities
compared to type II ﬁbers (all isoforms). However, in
women, type I ﬁbers are often larger than type IIA ﬁbers;
in rat skeletal muscle, it has been shown that type I ﬁbers
show similar or even larger CSA compared to type IIA
ﬁbers, while their SDH activities are signiﬁcantly lower
(Nakatani et al. 1999; Simoneau and Bouchard 1989;
Wust et al. 2009). Thus, it may well be that type I ﬁbers
are larger than type IIA ﬁbers and may be capable of
hypertrophy under various conditions and training regimes
(e.g., Alway et al. 1988; Andersen et al. 2008; Ianuzzo
et al. 1989). However, though the differences in size and
oxidative capacity between type I and IIA ﬁbers may be
too small to detect experimentally in humans, we
hypothesize, based on the data in Fig. 1, that the larger
type I ﬁbers would have relatively low oxidative capaci-
ties compared to the IIA ﬁbers. Based on the current
literature, it is generally safe to conclude that both type I
and IIA ﬁbers have a relatively large oxidative capacity
and small ﬁber size compared to type IIB/IIX ﬁbers. In
addition, these data also strengthen the observation from
Fig. 1 that the ﬁber size (and not necessarily the ﬁber
type) is related to its oxidative capacity.
The central question addressed in this review is: why do
high oxidative muscle ﬁbers remain relatively small com-
pared to low oxidative muscle ﬁbers? To gain insight into
the regulation of ﬁber size and the oxidative metabolism
and to reveal the gaps in the current knowledge, we will
give a quantitative inventory of ﬁber type-related differ-
ences in the structures and systems involved in synthesis
and degradation of muscle protein, as well as an overview
of the molecular pathways responsible for hypertrophy and
oxidative metabolism and of the way in which way these
pathways interact.
Fiber type-related differences in the machinery
for protein turnover
In skeletal muscle, there is continuous turnover of proteins,
and the balance between protein synthesis and degradation
(human cellular protein turnover: *0.8 g kg body weight
-1
day
-1 (Paddon-Jones and Rasmussen 2009) determines
how the functional parameters change, i.e., whether con-
tractile or mitochondrial protein is gained or lost. Muscle
protein synthesis involves both the genetic expression of
contractile and mitochondrial proteins themselves and the
expression and activation of co-factors controlling
expression of these proteins. The expression of contractile
and mitochondrial proteins is controlled by both the
mitochondrial and the nuclear genome. The synthesis
machinery comprises several major cellular components.
The availability of messenger RNA (mRNA), transfer
RNA (tRNA) and ribosomal RNA (rRNA), as well as their
initiation and elongation, are important in determining the
rate of synthesis. At the transcriptional level, the concen-
tration of mRNAs for particular proteins is determined by
the myonuclear and/or the mitochondrial density and the
transcription factors required for promoter activity. While
at the translational level, the number of ribosomes (i.e.,
rRNA) and the availability and the state of activation of
initiation and elongation factors control the rate of trans-
lation of mRNA into protein (Bolster et al. 2003).
Myonuclei and satellite cells
Since muscle ﬁbers are multinucleated cells, each myo-
nucleus controls transcription and consequent protein
synthesis of a limited amount of cytoplasm. In mammalian
as well as amphibian muscle ﬁbers, the number of
myonuclei is positively related to the cross-sectional area
of the ﬁbers (Allen et al. 1995; Jaspers et al. 2006).
Comparison of myonuclear numbers in high and low oxi-
dative ﬁbers has shown that high oxidative ﬁbers contain
more myonuclei per mm ﬁber length, per cross-sectional
area and consequently per volume cytoplasm (Burleigh
1977; Schmalbruch and Hellhammer 1977; Tseng et al.
1994). In mammals, the myonuclear density is around 40
per nanoliter cytoplasm in high oxidative ﬁbers and around
20 per nanoliter in low oxidative ﬁbers (Tseng et al. 1994).
In contrast, amphibian muscle shows about two to three
times lower myonuclear density (Jaspers et al. 2006),
which corresponds well with differences in physiological
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123temperature and a protein turnover rate that is about
threefold higher in mammalian muscle (Sayegh and Lajtha
1989). Several studies have demonstrated that muscle
hypertrophy is associated with, and dependent on, the
addition of newly formed myonuclei, whereas muscle
atrophy and disease appear to be associated with loss of
myonuclei. Together, these data suggest that the myonu-
clear domain is differentially regulated in high versus low
oxidative ﬁbers and that the number of myonuclei per ﬁber
may be important in maintaining size-related differences
between ﬁbers.
Based on the idea that each nucleus can only supply a
limited amount of cytoplasm with the necessary gene
transcripts, addition of myonuclei seems a prerequisite for
muscle ﬁber hypertrophy. As myonuclei lack the ability of
mitosis, nuclear accretion stems from a pool of normally
quiescent satellite cells that can be induced to differentiate
and proliferate and subsequently to fuse with existing
myoﬁbers. Although the debate regarding the requirement
of satellite cells for myonuclear accretion is ongoing, there
are indications that hypertrophy of rat and human muscle
ﬁbers by more than 25% is accompanied by the addition of
myonuclei (McCarthy and Esser 2007a; O’Connor and
Pavlath 2007; Petrella et al. 2006). This supports the nec-
essary role of myonuclei in the induction of hypertrophy. In
the heart, the number of nuclei does not increase during
hypertrophy. The limited adaptability of cardiomyocytes to
overload may partially underlie the development of chronic
heart failure occurring at 14 nuclei per nanoliter in rats
(Des Tombe et al. 2002). During postnatal development,
growth of the satellite cell population in skeletal muscle is
associated with an increased rate of nuclear accretion and
appears to be twofold higher in high than in low oxidative
ﬁbers (Lagord et al. 1998; Moss and Leblond 1971). In
adult rats, in the predominantly high oxidative soleus
muscle, 12% of the myonuclei belong to satellite cells,
whereas in the low oxidative extensor digitorum longus
muscle (EDL), the fraction is only 4% (Schultz et al. 2006).
In summary, in various vertebrate species, the high oxi-
dative skeletal muscle ﬁbers show higher densities of
myonuclei and larger populations of satellite cells com-
pared to low oxidative ﬁbers. Moreover, the rate of nuclear
accretion seems higher in high oxidative ﬁbers. Such
higher myonuclear density indicates that the high oxidative
ﬁbers may have a relatively larger potential for trans-
cription.
Mitochondrial DNA
Mammalian mitochondrial DNA (mtDNA) contains a
limited number of genes, which include those encoding 13
polypeptides that are essential for energy production via
oxidative phosphorylation, and 22 tRNA and 2 rRNA
genes. The mtDNA can replicate independently of nuclear
DNA (nDNA), but as in muscle cells the nDNA controls
the expression of all other mitochondrial and myoﬁbrillar
proteins, and mitochondrial synthesis requires the cooper-
ation of both the nuclear and mitochondrial genomes
(Hood 2001).
Few studies are available on the physiological regulation
of mitochondrial protein synthesis skeletal muscle and in
myocardium (Hock and Kralli 2009). In mammalian stri-
ated muscle, the concentrations of mtDNA, mtmRNA and
mtrRNA all vary in direct proportion to changes in oxi-
dative capacity. This, combined with the observation that
mitochondrial density is also proportional to the oxidative
capacity, both in vitro and in vivo, indicates that the
expression of mitochondrial genes in striated muscle is
proportional to their copy number (Hoppeler and Billeter
1991; van der Laarse et al. 1989; Williams 1986). Based on
these ﬁndings, it can be concluded that both myonuclear
and mitochondrial density are important for maintaining
synthesis of proteins associated with oxidative metabolism.
Since high oxidative ﬁbers show higher densities of
myonuclei and mitochondria, and mitochondrial biogenesis
requires both mitochondrial and nuclear DNA, their
capacity for mitochondrial protein synthesis is higher
compared to the low oxidative ﬁbers.
Transcription
Transcriptional control of myoﬁbrillar protein primarily
depends on the abundance and kinetic properties of RNA
polymerases, RNAses and the role of transcriptional co-
factors that modulate availability of RNA for translation.
Together, these properties determine the amount of avail-
able mRNA of speciﬁc genes in the cell.
It is currently unknown whether transcription rates of
RNA polymerases or RNAses differ between ﬁber types.
Biochemically measured transcription rates are in the range
of 1.0–4.3 kilobases min
-1 and have been suggested to be
gene dependent (Darzacq et al. 2007). In human muscle
tissue homogenates, an abundance of type I MyHC mRNA,
compared to total MyHC mRNA, is associated with high
protein synthesis rates, whereas abundance of type IIA
MyHC mRNA is associated with low protein synthesis
rates (Toth and Tchernof 2006). Several studies showed
that the rate of amino acid uptake was two- to threefold
higher in high than in low oxidative muscles (Goldberg
1967; Hood and Terjung 1987). Quantitative analysis of
RNA gene-bound and unbound fractions of RNA poly-
merase II showed that *75% of the polymerases were free
and diffusing, whereas the remaining 25% were immobile
and suggested to be engaged in transcription (Kimura et al.
2002). As only a quarter of the polymerase capacity is
engaged in transcription at a given time, this may suggest
Eur J Appl Physiol (2010) 110:665–694 669
123that the size of the RNA polymerase pool does not limit
transcriptional capacity.
Quantifying mRNA levels of structural muscle protein
in different ﬁber types requires accurate normalization,
which is usually done relative to housekeeping genes
necessary for basic cellular function (e.g., b-actin, GAPDH
and 18S rRNA). Apparently, expression levels of these
housekeeping genes can vary depending on the experi-
mental model, species, pathological condition (e.g., Bas
et al. 2004; Plomgaard et al. 2006) and the type of muscle
(Fig. 2; see supplementary section I for methods). To our
knowledge, very little comparative data are available
regarding gene transcription in high and low oxidative
muscle ﬁbers. Using in situ hybridizations, it has been
shown in rat muscle ﬁbers that the amount of MyHC
mRNA per microgram total RNA did not differ between
ﬁber types (Habets et al. 1999). However, the total RNA
content in high oxidative type I ﬁbers was twofold higher
compared to IIA ﬁbers and ﬁve- to sixfold higher than IIB
ﬁbers with the lowest oxidative capacity. As a consequence,
the MyHC mRNA content was substantially higher in high
compared to low oxidative ﬁbers. Thus far, ﬁber type-spe-
ciﬁc a-skeletal actin levels have not been reported. Using
a quantitative PCR technique, we have quantiﬁed that
predominantly high and low oxidative muscles contain
Fig. 2 Differences in mRNA concentrations of glyceralde-3 phos-
phate dehydrogenase (GAPDH), 18S RNA, a-skeletal actin (a-sk
actin), muscle ring ﬁnger-1 (MuRF1) and muscle atrophy F-box
(MAFbx) in high oxidative rat soleus (SO) and low oxidative extensor
digitorum longus (EDL) muscles (n = 6) (for methods see supple-
mentary section I). a Total RNA (lg) normalized to muscle tissue
weight (mg) showed that SO contains 2.3-fold more total RNA per
milligram muscle tissue compared to EDL (p\0.001). b mRNA
normalized to total RNA relative to EDL. No differences between SO
and EDL were found for any marker, except for GAPDH that showed
2.7-fold lower expression in SO (p\0.001). c mRNA normalized to
muscle tissue weight relative to EDL. GAPDH showed no signiﬁcant
difference between SO and EDL, whereas 18S RNA (2.1-fold), a-sk
actin (2.3-fold), MuRF1 (2.1-fold) and MAFbx (1.8-fold) were all
higher in SO (p\0.05). Asterisks indicate signiﬁcant difference
compared to EDL. Systematic comparison of oxidative capacity and
ﬁber cross-sectional area (CSA) from various hind limb muscles in
the rat (Armstrong and Phelps 1984) show that SO predominantly
(*90%) consists of slow contracting ﬁbers with high oxidative
capacity, whereas EDL contains largely (*60%) fast contracting
glycolytic ﬁbers with the lowest oxidative capacity. Within EDL, the
high oxidative ﬁbers show signiﬁcantly smaller CSA than low
oxidative ﬁbers and also high oxidative ﬁbers in SO show smaller
CSA compared to the low oxidative ﬁbers in EDL (Armstrong and
Phelps 1984; Nakatani et al. 1999). Based on these observations and
the data from Figs. 1 and 2, it can be concluded that high oxidative
ﬁbers are generally smaller and also contain more 18S RNA, a-sk
actin-, MuRF1- and MAFbx-mRNA, compared to low oxidative
ﬁbers. The literature on rat SO and EDL ﬁber type composition does
not unambiguously show that high oxidative ﬁbers have smaller CSA
compared to low oxidative ﬁbers (Deveci et al. 2001; Kupa et al.
1995; Torrejais et al. 1999). The inconsistencies in CSA data of the
latter studies compared to other studies with a more systematic
approach (Armstrong and Phelps 1984; Nakatani et al. 1999) may be
related to age, gender, muscle region or the effect of treatment. In
addition, the differences in CSA between high and low oxidative
ﬁbers were not always tested for statistical signiﬁcance. This impairs
comparison of these studies, largely because classiﬁcation of the
muscle ﬁber type highly depends on the reaction intensity of the
staining in different ﬁber cross sections and therefore may yield
considerable variation in the estimation of ﬁber populations
c
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123different levels of 18S rRNA and a-skeletal actin mRNA
(Fig. 2). Total RNA per microgram muscle tissue is 2.3-fold
higher in the high oxidative soleus compared to the low
oxidative EDL (Fig. 2a). The fraction of 18S rRNA and
a-skeletal actin mRNA on the total RNA is similar in both
muscles (Fig. 2b). However, taking into account normali-
zation per microgram muscle tissue, the 18S rRNA and
a-actin mRNA levels are 2.1 and 2.3-fold higher, respectively,
in soleus compared to EDL (Fig. 2c). Within Xenopus
ilioﬁbularis muscles, we found positive correlations (r
2=0.71
and r
2 = 0.54, p\0.0001) between mitochondrial density
and a-actin expression (Suppl. Fig. 1, see supplementary
section II for methods), which also indicates that within a
muscle high oxidative muscle ﬁbers contain higher a-actin
expression compared to low oxidative ﬁbers.
The 2.3-fold higher total RNA content in the high oxi-
dative rat soleus compared to the low oxidative EDL
(Fig. 2a) corresponds well with the study of Habets et al.
(1999), which showed two to sixfold higher total RNA
content in high compared to low oxidative ﬁbers. It appears
that high oxidative ﬁbers contain substantially more total
RNA, higher MyHC, a-actin mRNA as well as about
twofold higher myonuclear densities compared to low
oxidative ﬁbers. Based on these observations, it may be
hypothesized that the myonuclear density largely contrib-
utes to the availability of mRNA in high and low oxidative
ﬁbers. Further analysis needs to be done to test this
hypothesis.
Translation
About 80–85% of the cellular RNA is ribosomal, and in
human and rat heart muscle it has been shown that the
rRNA content reﬂects the number of ribosomes (Millward
et al. 1973; Razeghi et al. 2006). Assuming that the sta-
bility of mRNA, ribosomes and polysomes are similar in
high and low oxidative ﬁbers, the higher total RNA content
in the rat high oxidative soleus muscle compared to the low
oxidative EDL (Fig. 2a; Habets et al. 1999) implies that
high oxidative ﬁbers have a higher capacity to synthesize
protein.
In addition to the amount of ribosomes, the availability
and state of activation (i.e., state of phosphorylation) of
initiation and elongation factors and their binding proteins
can also be differentially regulated in ﬁber types. Habets
et al. (1999) showed that eukaryotic elongation factor
(eEF)-1a expression was higher in high oxidative ﬁbers.
For other factors affecting the rate of translation initiation
and elongation, only indirect information is available from
experiments studying the ﬁber type-speciﬁc expression and
activation of these factors in response to various exercise
protocols (see ‘‘Mechanical loading’’).
Co-factors affecting protein synthesis
Transcription rate and stability of mRNA are also regulated
by various co-factors that either enhance or inhibit the
expression of muscle genes. For example, recently discov-
ered microRNAs (miRNAs) negatively regulate protein
synthesis by targeting mRNA for degradation thereby
inhibiting transcription, or by blocking mRNA binding sites
and subsequently inhibiting translation (Bartel 2004). Thus
far, four skeletal muscle-speciﬁc miRNAs (miRNA-1, -133,
-206, and -208) have been shown to be involved in prolif-
eration and differentiation of myoblasts (Chen et al. 2006),
cardiac function and hypertrophy (Sempere et al. 2004).
Differential expression in low and high oxidative muscles
was found for miRNA-206, which was sevenfold higher in
the high oxidative soleus compared to the low oxidative
plantaris, whereas expression levels of other miRNAs were
similar in these muscles (McCarthy and Esser 2007b).
These results indicate that miRNAs can be differentially
regulated in high and low oxidative ﬁbers. Whether miR-
NA-206andothermiRNAs indeedhave aﬁbertype-speciﬁc
function and whether they have a role in regulating mRNA
levels during ﬁber size adaptation require further inves-
tigation.
Fiber type–ﬁber size paradox
Taken together, high oxidative ﬁbers have a larger
potential for transcription (i.e., satellite cells, myonuclei,
mitochondria and mRNA) compared to low oxidative
ﬁbers. Also, these ﬁbers show a relatively large total
ribosomal protein content. This indicates that high oxi-
dative ﬁbers possess a larger capacity for protein syn-
thesis, which seems paradoxical since these ﬁbers remain
relatively small. However, this apparent paradox may not
be a quantitative one, as there is a discrepancy in mass of
large myoﬁbrillar proteins and much smaller oxidative
proteins. On the other hand, several factors involved in
translation initiation and elongation are differentially
expressed and activated in high and low oxidative ﬁbers.
This could suggest that one or more of these components
of the synthesis machinery are less responsive to con-
tractile activity in high oxidative ﬁbers, thereby reducing
translational efﬁciency and limiting the capacity to syn-
thesize myoﬁbrillar protein. Alternatively, if translational
efﬁciency or the function of other components of the
synthesis machinery is not impaired, then the protein
synthesis rate is likely to be balanced by a high rate of
protein degradation resulting in a higher turnover rate in
the high oxidative ﬁbers. The latter would imply a larger
capacity of the machinery for protein degradation in high
oxidative ﬁbers.
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degradation
The rate of protein degradation in skeletal muscle is largely
controlled by oxidative stress and three proteolytic enzy-
matic pathways: (1) the lysosomal system; (2) calcium-
mediated proteases such as caspases and calpains; (3) the
ubiquitin–proteasome system (Powers et al. 2007). In
addition, expression and activation of several co-factors
lead to enhanced or decreased activity of the catalytic
enzymes. The susceptibility of proteins to degradation may
also depend on conformational stability of the protein,
which is determined by factors such as the intracellular
temperature, reactive oxygen species, cellular energy status
and pH. Modulation of protein degradation rate affects the
rate of protein turnover and largely determines whether
contractile protein is gained or lost. As a consequence, an
increase in the rate of catabolism at a constant rate of
protein synthesis results in muscle atrophy.
Lysosomal proteolysis
During muscle atrophy, lysosomal cathepsins have been
suggested to be involved in initial breakdown of sarco-
lemmal proteins such as channels and receptors. Sub-
sequent ubiquitination of these proteins make them target
for lysosomal systems, thereby reducing their contribution
to protein synthesis. In vitro, cathepsins appear responsible
for breaking down myoﬁbrillar protein (Dufour et al. 1989;
Mayer 2000). Although assessing the role of lysosomal
proteolysis is strenuous as it requires massive inhibition of
all types of lysosomal proteases, increased activities of
cathepsin have been shown in soleus and extensor digito-
rum muscles from hind limb-suspended rats with higher
concentrations being found in the soleus (Goldspink et al.
1986). Others have also reported that high oxidative ﬁbers
of rat contain higher levels of cathepsin than low oxidative
ﬁbers suggesting a higher potential for degradation in these
ﬁbers (Kominami et al. 1985). These results are consistent
with the observation that cathepsins are present in high
levels in tissues with high protein turnover (Bechet et al.
2005).
Calcium-dependent proteolysis
Ca
2?-dependent proteases such as calpains and caspases
are involved in breaking down cytoskeletal and myoﬁbr-
illar proteins. Calpain isoforms (e.g., l-calpain and m-
calpain) can be activated by different concentrations of
cytoplasmic calcium and are mainly known for cleaving
cytoskeletal proteins that anchor the myoﬁbrillar proteins,
such as nebulin and titin (Goll et al. 2003). Many caspases
have been identiﬁed of which several are important in
muscle degradation (see for review Powers et al. 2007). In
skeletal muscle, caspases are particularly involved in
myonuclear apoptosis and degradation of the actin–myosin
complex. During conditions of disuse, calpains and casp-
ases are up-regulated and inhibition of calpains results in
attenuation of the atrophy. As a result of the activity of
caspases and calpains, monomeric actin and myosin pro-
teins become available for degradation by the proteasome
(Du et al. 2004; Taillandier et al. 1996) (see below).
It is unknown whether a ﬁber type-speciﬁc response in
calcium-mediated proteolysis exists. However, intracellular
calcium concentrations [Ca
2?]i are generally high in car-
diac myocytes and high oxidative skeletal muscle ﬁbers
(Batkai et al. 1999; Dibb et al. 2007). As high [Ca
2?]i are
associated with increased calpain and caspase activity, we
hypothesize higher activities of caspases and calpains in
high compared to low oxidative ﬁbers, which would imply
a higher rate of cytoskeletal protein degradation in these
high oxidative myocytes.
Proteasome-mediated proteolysis
The ubiquitin–proteasome system is responsible for
breakdown of the majority of myoﬁbrillar proteins and is
both ATP and ubiquitin dependent (Taillandier et al. 1996).
In the process of ubiquitination, proteins are marked for
degradation by three classes of enzymes, known as E1
(activating), E2 (conjugating) and E3 (ligating), after
which the proteasome degrades the ubiquitin substrates.
During various conditions of disuse, such as denervation,
unloading, hind limb suspension and fasting, the expression
of two muscle-speciﬁc ubiquitin-ligases, muscle atrophy
F-box (MAFbx/atrogin-1) and muscle ring ﬁnger (MuRF),
was found to be up-regulated. Inhibition of either one
resulted in attenuation of atrophy (Bodine et al. 2001a).
MAFbx and MuRF are controlled by the Forkhead box
transcription factors O (FOXO) subfamily of transcription
factors and the nuclear factor kappa-B (NF-jB) (Nordquist
et al. 2007; Sandri et al. 2004). MAFbx and MuRF con-
tribute to atrophy by up-regulation of proteasome compo-
nents and by inhibition of transcription of slow-type
structural muscle genes and translation (see also ‘FOXO–
E3 ligase–proteasome pathway’ and ‘NF-jB pathway’).
To our knowledge, there are no experimental data
available on ﬁber type-speciﬁc expression of ubiquitin-
ligases or proteasome components. We quantiﬁed both
MAFbx and MuRF mRNA expression relative to total
RNA and found no difference between high oxidative
soleus and low oxidative EDL (Fig. 2b). However, as the
soleus contains 2.3-fold more total RNA per muscle tissue
weight (Fig. 2a), expression levels of MAFbx and MuRF
are signiﬁcantly higher (1.8- and 2.1-fold, respectively)
compared to EDL (Fig. 2c). In contrast, FOXO1 mRNA
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soleus compared to the low oxidative gastrocnemius, tibi-
alis anterior and quadriceps muscles (Allen and Unterman
2007). In vivo, FOXO1 inhibits expression of high oxida-
tive ﬁber-related genes and the function of oxidative
metabolism-enhancing factors (Kamei et al. 2004). In
addition, skeletal muscles of FOXO1 over-expressing mice
had fewer type I ﬁbers as well as smaller type I and type II
ﬁbers (all isoforms) (Kamei et al. 2004).
Oxidative stress-mediated proteolysis
Classical in vitro experiments have shown that 2–5% of
total oxygen becomes a superoxide or free radical (Boveris
and Chance 1973). This may overestimate in vivo rates of
oxidant production as assessment of ROS production from
different sites in mitochondria indicated that upper esti-
mates of proportion of the electron ﬂow giving rise to
superoxide was only 0.15% (St-Pierre et al. 2002). Despite
the controversy on estimating the proportion of free radi-
cals in vivo (Jackson et al. 2007; Murphy 2009), mito-
chondria can be considered the major source of free
radicals since electron transport accounts for *85% of the
oxygen consumed by the cell (Challoner 1968). Under
normal physiological conditions (i.e., normal PO2 levels), a
variety of reactive oxygen species (ROS) and reactive
nitrogen species (RNS) are produced in skeletal muscle
ﬁbers, which play a critical role in the adaptation of muscle
(for review see Jackson et al. 2007; Powers et al. 2007). At
normal PO2 levels, ROS promote adaptation and survival
in many cell types. However, under conditions of oxidative
stress (i.e., hypoxia or hyperoxia), ROS production
increases and induces myonuclear apoptosis in vivo and in
vitro (Duranteau et al. 1998). High levels of ROS (e.g., as a
result of exercise or reperfusion injury) activate caspases
via Ca
2? release from the sarcoplasmatic reticulum and
also induce mitochondrial permeability transition followed
by cytochrome c release, which leads to myonuclear
apoptosis and myoﬁbrillar degeneration (Garrido et al.
2006; Primeau et al. 2002). In addition, ROS are also
involved in regulating Ca
2?-meditated proteolysis (through
calpain activation) and increased proteasome activity
through NF-jB and the E3 ligases (Powers et al. 2007).
In relation to exercise, many studies have shownelevated
ROS production, which is assumed to be associated with the
increased oxygen consumption that occurs with elevated
mitochondrial activity (Herrero and Barja 1997; Malinska
et al. 2009; Powers et al. 1999). However, exercise also
induces antioxidant production and structural changes of
the mitochondria, which have been related to a reduction in
free radical concentration (Anderson and Neufer 2006;
Leeuwenburgh et al. 1997; Molnar et al. 2006). Recently, it
has been suggested that the production of ROS and
antioxidant scavengers may be tightly regulated by an
internal control mechanism, involving uncoupling proteins
and antioxidants (Brand et al. 2004). Such a mechanism
would keep ROS concentrations in the cell within a range
that is beneﬁcial for cellular survival. To our knowledge,
measurements on intracellular ROS generation and scav-
enging in high and low oxidative ﬁbers have not been
undertaken, but the available data for muscle cells indicate
that contractile activity increases ROS production two to
fourfold (McArdle et al. 2005; Vasilaki et al. 2006). As
antioxidant production also increases with exercise, this
may indicate that ROS and antioxidant scavengers are both
higher in high oxidative ﬁbers compared to low oxidative
ﬁbers. As yet the relative differences in ROS concentrations
between ﬁber types and their role in regulating ﬁber size are
not clear. To obtain insight into the contribution of ROS in
the ﬁber type-related regulation of size, future experiments
need to determine the concentrations of different types of
free radicals and their scavengers in high and low oxidative
ﬁbers by systematically assessing the numerous endogenous
sites and sources that produce ROS and antioxidants.
Pathways and stimuli regulating protein turnover
in different ﬁber types
Fromtheﬁrstpartofthisreview,itbecomesevidentthathigh
oxidative muscle ﬁbers show a larger potential for protein
synthesis and that some components of the degradation
machinery are also present in higher quantities compared to
low oxidative ﬁbers. This suggests that high oxidative ﬁbers
have a relatively high rate of protein turnover, which may
limit hypertrophy in these ﬁbers. The machinery for protein
turnover is regulated by many different pathways and stim-
uli.Sincemuscleﬁbershavelimitedcapacitytohypertrophy
and increase oxidative capacity at the same time, this may
imply that competition exists between turnover rates of
structural muscle protein (i.e., myoﬁbrillar proteins) and
protein involved in metabolism (i.e., mitochondrial pro-
teins). Such competition is likely the result of interactions
between signaling pathways either involved in synthesis or
breakdown of the structural and metabolic proteins. The
stimuli regulating these pathways are related to muscle
activity (frequency and ﬁring pattern of action potentials,
intracellular calcium), mechanical loading, growth factors,
vitamins, binding factors and cytokines and factors associ-
atedwithcellularenergyandoxygenlevels,suchashypoxia,
redox potential and AMP:ATP ratio.
Signaling pathways involved in muscle protein turnover
Several signaling pathways are known for their role in
regulation of muscle ﬁber size (Suppl. Fig. 2A–E). These
Eur J Appl Physiol (2010) 110:665–694 673
123pathways control the rate of protein turnover at the level of
transcription (calcium/calmodulin pathways; MAP-kinase
pathways), translation (PI3K–Akt–mTOR), degradation
(FOXO–E3 ligase–proteasome and NF-jB pathway) or a
combination of these (AMPK–PGC-1a). The interactions
between the pathways (Fig. 3) determine the rates of pro-
tein synthesis and degradation and whether contractile or
metabolic protein is gained or lost.
Calcium/calmodulin pathways
Intracellular calcium [Ca
2?]i regulates the activity of calci-
neurin, a serine/threonine phosphatase, and calcium/
calmodulin protein kinase (CaMK), both in a calmodulin-
dependent way (Klee et al. 1998; Schulman 1993). Activity
of calcineurin is enhanced in skeletal muscle in response to
sustained low-amplitude oscillations of [Ca
2?]i while it
remains insensitive to transient high-amplitude oscillations
of [Ca
2?]i (Dolmetsch et al. 1997). In contrast, CaMKII and
CaMKIV respond to physiological high-amplitude Ca
2?
signals,which, inskeletalmuscle,correspondtoCa
2?levels
achieved atstimulationfrequencieshigherthan30 Hz(Chin
2005).DownstreamtargetsofcalcineurinandCaMK(Suppl.
Fig. 2A) are myogenic transcription factors, such as nuclear
factorofactivatedTcells(NFAT),myocyteenhancerfactor-
2 (MEF-2) and serum response factor (SRF) (Davis et al.
2003; Dolmetsch et al. 1997; Wu et al. 2001). Activation of
calcineurin and CaMK causes conformational changes of
these transcription factors, which either activate them or
stimulate translocation from cytoplasm to the nucleus.
Calcineurin has been attributed a ﬁber type-speciﬁc role
in inducing fast-to-slow transitions in MyHC isoforms
(Chin et al. 1998). In addition, calcineurin regulates a large
subset of genes involved in oxidative metabolism (for
instance myoglobin) and increased glucose uptake and
fatty acid oxidation (Bigard et al. 2000; Chin 2005) (Suppl.
Fig. 3 Interactions of signaling pathways and their stimuli involved
in turnover of structural muscle (i.e., contractile) protein and protein
associated with high oxidative metabolism. In response to contractile
activity, calcium increases intracellularly through stretch-activated
Ca
2? channels and from calcium stores. In addition, growth factors
and cytokines are secreted in the extracellular matrix by the muscle
ﬁbers where they can bind receptors and activate signaling pathways.
The type of contractile activity or mechanical loading combined with
the balance between cellular energy (AMP:ATP) and oxygen levels
(i.e., ROS production) determine ﬁber type-speciﬁc activation of
pathways and thus whether contractile protein is gained or lost (for
details see text). AAs amino acids, AMPK AMP-activated protein
kinase, bFGF basic ﬁbroblast growth factor, ECM extracellular
matrix, FAK focal adhesion kinase, FOXO Forkhead box transcription
factors O subfamily, GF ? CK growth factors and cytokines, HGF
hepatocyte growth factor, IL interleukin, IGF-I insulin-like growth
factor-I, MAFbx muscle atrophy F-box, MAPK mitogen-activated
protein kinases, MGF mechano-growth factor, mTOR mammalian
target of rapamycin, MuRF muscle ring ﬁnger, NF-jB nuclear factor
kappa-B, PGC-1a peroxisome proliferator-activated receptor c coac-
tivator-1a, PI3K phosphatidylinositol-3 kinase, PLD phospholipase
D, p70S6K 70-kDa ribosomal protein S6 kinase, ROS reactive oxygen
species, SC satellite cells, SR sarcoplasmatic reticulum, SRF serum
response factor, TNF-a tumor necrosis factor-a, Vps34 vacuolar
protein sorting mutant 34
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chondrial biogenesis through increased expression of per-
oxisome proliferator-activated receptor c co-activator 1a
(PGC-1a) (Lin et al. 2002; Wu et al. 2002) (see ‘AMPK–
PGC-1a’). However, controversy exists on the role of
calcineurin and CaMK in regulating ﬁber size.
Calcineurin appears to be involved in myonuclear accre-
tion in high, but not in low oxidative ﬁbers (Mitchell et al.
2002). The hypertrophic effects of calcineurin are also
indicated by the hypertrophic response of myoblasts in cul-
ture while exposed to activated calcineurin (Musaro et al.
1999; Semsarian et al. 1999). Furthermore, inhibition of
calcineurin activity during mechanical overload, recovery
fromdisuseatrophyorinmusclesfromtransgenicmiceover-
expressing insulin-like growth factor-I (IGF-I) showed
blocking of the hypertrophic response (Dunn et al. 1999;
Mitchell et al. 2002; Musaro et al. 1999; Semsarian et al.
1999). In contrast, other studies using various models of
hypertrophy did not show an active role for calcineurin in
increasingﬁbersizeinmusclesofmiceandrats(Bodineetal.
2001b;Musaroetal.2001;Serranoetal.2001).Furthermore,
mice over-expressing calcineurin showed no evidence for
hypertrophy (Naya et al. 2000). Altogether, it appears that
calcium/calmodulin-activated pathways are particularly
involved in the synthesis of slow-type gene expression and
oxidative metabolism. In addition, although activation of
calcineurin alone is not sufﬁcient for inducing hypertrophy,
itmaydoso,forexample,incombinationwithotheressential
pathways mediated by IGF-I (see growth factors).
MAPKinase pathways
The three best characterized subfamilies of mitogen-acti-
vated protein kinase (MAPK) signaling are (1) c-Jun
N-terminal kinase (JNK); (2) extracellular regulated kinase
(ERK); and (3) the 38 kDa stress-activated protein kinase
(p38). Activation of MAPK is mediated by a set of three
sequential protein kinases that are generally induced by: (1)
receptor binding of stimuli (e.g., IGF-I); 2) protein kinase
C activation; or (3) by integrin or dystroglycan signaling
(Carson and Wei 2000; Florini et al. 1996; Rando 2001;
Ruwhof and van der Laarse 2000). Activated MAPK will
phosphorylate and activate myogenic and metabolic tran-
scription factors, as well as other kinases that affect
downstream signal transduction (Suppl. Fig. 2B). The ﬁber
type-speciﬁc functions of ERK, JNK and p38 in muscle are
brieﬂy summarized.
The ERK pathway is involved in regulation of protein
synthesis, particularly in the induction of slow ﬁber pheno-
types and the up-regulation of genes involved in glucose
transport,glyconeogenesisandangiogenesis(Koulmannand
Bigard 2006; Murgia et al. 2000). Furthermore, ERK has
been shown to reduce proteasome activity, mitochondrial
breakdown and myonuclear apoptosis, thereby promoting
cellular survival (Powers et al. 2007). In addition, ERK has
also been attributed a role in stretch-induced cardiac
hypertrophy by increasing c-fos and a-actin expression
(Sadoshima and Izumo 1993; Yazaki and Komuro 1992).
Although very little data are available on ﬁber type-speciﬁc
MAPK expression and/or activity, ERK-1 and ERK-2 con-
centrations are signiﬁcantly different in rat soleus and EDL
muscles, with more ERK being present in the high oxidative
soleus (Atherton et al. 2004; Wretman et al. 2000). This
mightsuggestaﬁbertype-speciﬁcroleforERK.Ontheother
hand, ERK is also critically related to IGF-I-induced
hypertrophy in rat plantaris (Haddad and Adams 2004),
whichispredominantlycomposedoftypeIIﬁbers(typeIIA:
*40%, type IIB: *40%; (Armstrong and Phelps 1984).
This might also suggest a role for ERK in ﬁber type-related
regulation of size.
Activation of p38 promotes PGC-1a expression and
subsequent mitochondrial biogenesis (Akimoto et al. 2005)
(Suppl.Fig. 2B).Otherdownstreamtargetsofp38areMEF-
2, which is involved in slow-type gene expression, and p53
that mediates myonuclear apoptosis (Powers et al. 2007).
The p38 MAPK pathway also plays a role in protein degra-
dation by promoting MAFbx expression and activation of
NF-jB (Li et al. 2005; Powers et al. 2007; Zhao et al. 1999).
Among the speciﬁc targets of JNK are c-jun, c-myc and
ATF-2, which are involved in the expression of structural
muscle protein (Clerk and Sugden 1997) (Suppl. Fig. 2B).
JNK is also active during oxidative stress and mediates
myonuclear apoptosis and mitochondrial breakdown (Pow-
ersetal.2007).Toourknowledge,therearenodataavailable
on ﬁber type-speciﬁc expression of p38 and JNK except in
response to various activity protocols (see ‘‘Mechanical
loading’’).
MAPKs differ in their interaction with transcription
factors, providing a tool for selectively targeting tran-
scription factors. Although the function of p38 in muscle
remains ill deﬁned, the current literature indicates that p38
is involved in high oxidative gene expression and also in
proteasome-mediated degradation. JNK induces gene
expression of structural muscle proteins and promotes
myonuclear apoptosis, whereas ERK mainly has a protec-
tive role in promoting cellular survival and stimulating the
oxidative metabolism. However, as each MAPK shares
targets and functions with many upstream and downstream
kinases and transcription factors, speciﬁcity of the pathways
and their ﬁber type-speciﬁc role are not fully resolved.
PI3K–Akt–mTOR
A central pathway involved in hypertrophy is regulated at
the translational level by the serine/threonine kinase Akt
(or PKB). In muscle, Akt is activated by the upstream
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123phosphatidylinositol 3-kinase (PI3K), either induced by
receptor binding or by integrin-mediated activation of focal
adhesion kinase (FAK), such as in cardiac myocytes
(Franchini et al. 2000; Sakamoto et al. 2002) (Fig. 3). PI3K
activates Akt, which then has the ability to phosphorylate
and change the activity of many signaling molecules.
Among these are the mammalian target of rapamycin
(mTOR) and glycogen synthase kinase-3b (GSK-3b),
which play a crucial role in the regulation of translation
(Cross et al. 1995). Akt activates mTOR via phosphory-
lation and inactivation of tuberous sclerosis complex-2
(TSC-2) (Manning et al. 2002; Potter et al. 2002). Subse-
quently, mTOR phosphorylates and activates the 70-kDa
ribosomal protein S6 kinase (p70S6K), which results in
increased translation either directly or indirectly by acti-
vating initiation and elongation factors, eIF-2, eIF-4E
(through 4E-BP) and eEF-2 (Bodine et al. 2001b; Horn-
berger et al. 2001) (Suppl. Fig. 2C). In addition, Akt also
phosphorylates and inactivates GSK-3b, thereby activating
translation via initiation factor eIF-2B (Jefferson et al.
1999). Other functions of Akt comprise the negative reg-
ulation of protein degradation by inhibiting FOXO-medi-
ated proteasome activity (Stitt et al. 2004) (see ‘FOXO–E3
ligase–proteasome pathway’). However, Akt has also been
associated with up-regulation of the proteasome through
activation of NF-jB (see NF-jB pathway) in a PI3K-
dependent process (Russell et al. 2008). In addition, Akt
functions as negative regulator of the oxidative metabolism
by inhibiting AMP-activated protein kinase (AMPK)
(Hahn-Windgassen et al. 2005) (see ‘AMPK–PGC-1a’).
Although it is clear that the PI3K–Akt–mTOR pathway
plays a crucial role in regulating hypertrophy, the ﬁber
type-speciﬁc role of this pathway remains unclear. Akt
appears to be differentially regulated in high and low
oxidative muscles, as it has been shown that both total and
phosphorylated Akt concentrations were substantially
higher in rat soleus compared to EDL (Sakamoto et al.
2002). On the other hand, also in rat EDL muscle, it was
shown that total p70S6K was sixfold higher than in the
soleus (Atherton et al. 2004), but the fraction of the
phosphorylated protein was substantially lower in EDL
compared to the soleus (27 vs. 64%) (Hornberger et al.
2001). Currently, it is unknown whether high and low
oxidative ﬁbers contain similar absolute concentrations of
phosphorylated p70S6K; however, it appears that that the
low oxidative ﬁbers have a larger potential for increasing
the phosphorylation state (i.e., activation) of p70S6K and
subsequent translation compared to high oxidative ﬁbers.
FOXO–E3 ligase–proteasome
During various conditions of disuse, FOXO transcription
factors up-regulate the expression of ubiquitin-ligases
(MAFbx and MuRF), which are associated with increased
proteasome activity and protein degradation (Lecker et al.
2004; Sandri et al. 2004; Stitt et al. 2004) (Suppl. Fig. 2D).
As mentioned above, in response to hypertrophic stimuli,
Akt inhibits protein degradation by phosphorylating
FOXO, which results in nuclear exclusion of FOXO and a
decreased transcription of FOXO target genes (Sandri et al.
2004). However, during muscle atrophy, MAFbx is up-
regulated and prevents the Akt-dependent phosphorylation
of FOXO (Schisler 2008). Consequently, FOXO remains
located in the nucleus causing enhanced expression of
MAFbx and MuRF. The expression of MAFbx further
increases in a feed-forward mechanism with FOXO,
thereby stimulating protein degradation. In addition, FOXO
and ubiquitin-ligases also negatively affect protein syn-
thesis. For example, FOXO has been shown to inhibit
mTOR signaling, whereas MAFbx targets eIF-3 for deg-
radation (Suppl. Fig. 2D) thereby attenuating protein
translation (Lecker et al. 2004; Southgate et al. 2007). At
the transcriptional level, FOXO reduces the expression of
calcineurin and transcription factors MEF-2 and NFAT,
which may attenuate slow-type gene expression (Kamei
et al. 2004; Ni et al. 2006) (Suppl. Fig. 2A, 2D).
FOXO1 expression, normalized to b-actin, in low oxi-
dative mouse muscles is higher compared to the high
oxidative soleus muscle (Allen and Unterman 2007). Based
on the above-mentioned feed-forward mechanism between
FOXO and MAFbx, it can be hypothesized that protein
degradation is higher in the low oxidative ﬁbers. However,
our results show that both MAFbx and MuRF expression
was about twofold higher in high oxidative ﬁbers (Fig. 2c).
In addition, it appears that FOXO is not involved in atrophy
per se, as FOXO1 and FOXO3a proteins are unaltered in
human vastus lateralis after 20 days of unilateral limb
suspension (Sakuma et al. 2009). These results suggest that
an alternative route besides FOXO exists that is capable of
inducing the expression of E3 ligases, MAFbx and MuRF.
Altogether, FOXO-mediated E3 ligase-proteasome activity
appears to play an important role in reducing the ﬁber size
during disuse, both by increasing the rate of protein deg-
radation and by attenuating the rate of protein synthesis.
However, it remains to be investigated in what way FOXO
expression changes in response to various training stimuli
and whether FOXO is also capable of limiting ﬁber size in
response to hypertrophic stimuli.
NF-jB pathway
The NF-jB family of transcription factors is also involved
in proteolysis during muscle atrophy. Speciﬁc NF-jB
members have been related to atrophy and cachexia in
response to disuse and chronic diseases (Jackman and
Kandarian 2004). NF-jB is an important transcription
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expression of E2 and E3-ligases in mice leg muscles (Cai
et al. 2004). However, whether NF-jB directly or indi-
rectly affects the E3-ligases has not been elucidated yet.
It is clear that NF-jB induces atrophy (Suppl. Fig. 2D,
Fig. 3), but whether this is FOXO dependent also remains
to be determined.
In rats, overall nuclear NF-jB (p65) expression was
found to be 56% higher in high oxidative soleus compared
to the low oxidative superﬁcial vastus lateralis (Phillips and
Leeuwenburgh 2005). NF-jB levels in rat soleus muscle
were also threefold higher compared to those in EDL
(Atherton et al. 2004). In addition, NF-jB showed a tenfold
higher activation in soleus of rat after 7 days of unloading,
whereas in EDL no change was detected (Hunter et al.
2002). These results indicate a differential expression of
NF-jB between ﬁber types, suggesting that NF-jB-
induced E3 ligase-proteasome activity is higher in high
oxidative ﬁbers. In addition, high levels of NF-jB signal-
ing have also been associated with reduced myonuclear
apoptosis in mice and rats (Phillips and Leeuwenburgh
2005). This effect could be related to the NF-jB-induced
inhibition of anti-apoptotic genes (e.g. bcl-2) (Perkins
2000). Altogether, NF-jB appears to play a role in
inducing E3 ligase-proteasome activity, particularly in high
oxidative ﬁbers and is also involved in regulating myonu-
clear apoptosis.
AMPK–PGC-1a
AMPK is a highly conserved protein kinase that plays a
role in the regulation of many cellular processes. In
mammalian adult muscle tissue, AMPK function includes
induction of glucose transport, glycogen metabolism, fatty
acid oxidation and transcriptional regulation of structural
muscle genes (Hardie and Sakamoto 2006).
AMPK controls several processes via the transcriptional
co-activator PGC-1a (Suppl. Fig. 2E). PGC-1a, and also
functionally similar PGC-1b, are involved in inducing
mitochondrial biogenesis and slow-type gene expression
via MEF-2 and NFAT (Arany et al. 2007; Garnier et al.
2005; Lelliott et al. 2006; Lin et al. 2002). The regulation
of high oxidative gene expression by PGC-1 is mediated by
interactions with different isoforms of a family of nuclear
hormone receptors, the peroxisome proliferator-activated
receptors (PPARs) (Gilde and Van Bilsen 2003). AMPK
induces the expression of PGC-1a as well as the activation
and expression of PPAR isoforms (Lee et al. 2006; Narkar
et al. 2008). AMPK expression appears to be similar in
high and low oxidative ﬁbers, while basal AMPK phos-
phorylation is higher in type IIA ﬁbers compared to type I
and IIB ﬁbers (Lee-Young et al. 2009). Concentrations of
PGC-1a and PPAR isoforms (b and d) appear to be higher
in high oxidative ﬁbers suggesting that the AMPK–PGC-1a
pathway induces a ﬁber type-speciﬁc increase in genes
associated with high oxidative metabolism (Lin et al. 2002;
Narkar et al. 2008).
Another role of AMPK comprises the inhibition of
protein synthesis. It has been well established that AMPK
activation suppresses the translation of myoﬁbrillar protein
by inhibiting the mTOR–p70S6K pathway via activation of
TSC-2 and by phosphorylation and inactivating eEF-2
(Chan and Dyck 2005; Inoki et al. 2003; Mounier et al.
2009). This interaction indicates that AMPK, in addition to
being a stimulus of biosynthesis of mitochondria, is an
inhibitor of protein synthesis.
Recently, AMPK has also been linked to protein deg-
radation since AMPK activation increases the expression of
E3 ligases, MAFbx and MuRF (Krawiec et al. 2007).
Several studies have shown that AMPK also activates NF-
jB signaling in vitro (Jung et al. 2004; Okayasu et al.
2008). Although AMPK activation also has been related to
suppression of NF-jB, presumably through reduced cyto-
kine expression (Li et al. 2007), there are multiple NF-jB
family members that are involved in muscle wasting
(Hunter et al. 2002). Therefore, the AMPK-induced NF-jB
activation may indicate that AMPK signaling increases
protein degradation. AMPK may also induce protein
degradation through an interaction between PGC-1a and
FOXO-mediated protein degradation. Kamei et al. (2004)
hypothesized that FOXO inhibits PGC-1a function by
binding PGC-1a. However, high expression levels of PGC-
1a have also been associated with decreased MAFbx and
MuRF protein levels (Sa ´inz et al. 2009). In addition, Sandri
et al. (2006) also showed reasonable data to suggest that
PGC-1a inhibits FOXO function. The latter studies raise
serious concerns about the role of PGC-1a in protein
degradation. Whether AMPK executes its different roles
simultaneously in response to its activation remains to be
determined, but there are indications that AMPK reduces
cell differentiation of myoblasts, thereby reducing hyper-
trophy, without necessarily accelerating protein degrada-
tion (Fulco et al. 2008). This would suggest that other
signaling components were also capable of inducing NF-
kB-mediated protein degradation. Thus, although there
appears to be an interaction between AMPK and NF-jB,
clearly more research is necessary to clarify the role of the
AMPK–PGC-1a pathway in protein degradation.
In conclusion, AMPK stimulates the oxidative metabo-
lism and slow-type gene expression through PGC-1a and
simultaneously attenuates synthesis of protein by inhibiting
mTOR and the rate of translation of mRNA. As Akt, which
activates mTOR, negatively regulates high oxidative gene
expression by inactivating AMPK (see ‘PI3K–Akt–mTOR
pathway’), competitive interaction exists between signaling
pathways regulating structural and metabolic protein
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ously led to the hypothesis that Akt–AMPK serves as a
‘switch’ between pathways inducing a high or a low oxi-
dative phenotype, thereby regulating the muscle ﬁber size
(Atheron et al. 2005; Baar 2006). However, the Akt–
mTOR and AMPK interactions may be more complex than
suggested by a ‘switch’ mechanism. For example, mTOR
activation has been shown to increase mitochondrial gene
transcription by interaction with PGC-1a (Cunningham
et al. 2007). Also, knockdown of mTOR-binding protein
Raptor has been shown to down-regulate genes involved in
mitochondrial biogenesis (e.g., PGC-1a) and hyperactiva-
tion of Akt, suggesting that mTOR is not only required for
hypertrophy but also for regulation of metabolic function
(Bentzinger et al. 2008).
Stimuli and the status of activity of ﬁber type-speciﬁc
signaling pathways
In vivo, multiple signals or stimuli are received by muscles,
which trigger one or more of the above-mentioned sig-
naling pathways involved in the regulation of muscle
protein turnover. The key stimuli are all related to the type
of contractile activity, ranging from sustained, low force
activity (endurance training) to short and high force
activity (resistance training). Contractile activity and the
associated mechanical loading can activate these pathways
either directly or indirectly via changes in [Ca
2?]i and the
expression of growth factors and cytokines. In addition,
changes in cellular energy and oxygen levels, which are
affected by contractile activity as well, also regulate acti-
vation of signaling pathways speciﬁc for high and low
oxidative ﬁbers.
Mechanical loading
Mechanical loading is associated with the regulation of
muscle mass; however, the cellular and molecular mecha-
nisms that contribute to the transduction of mechanical
signals into a hypertrophic response are complex and still a
matter of ongoing research. The MAPKinase and the Akt–
mTOR pathways play important roles in increasing the rate
of protein synthesis in response to mechanical loading
(Glass 2005; Ruwhof and van der Laarse 2000), particu-
larly by increased expression of growth factors (see below).
Recently, other growth factor-independent mechanisms
have been proposed that connect mechanical events at the
membrane to the intracellular signaling structure, among
which are the stretch-activated channels (SACs) and the
integrin-focal adhesion complexes (FACs) (Spangenburg
2009). The inhibition of SACs has been shown to result in
attenuation of the Akt–mTOR signaling pathway, reduced
hypertrophy and a lack of expected functional adaptations
in response to loading (Butterﬁeld and Best 2009; Spang-
enburg and McBride 2006). It has been hypothesized that
the SACs allow the inﬂux of ions such as Ca
2?, which
affects both protein synthesis and degradation (Yeung et al.
2005) (see ‘‘Intracellular calcium’’).
The integrin-focal adhesion complexes seem to be
involved in conversion of mechanical signals into intra-
cellular signals. In endothelial cells, mechanical loading is
associated with the recruitment of proteins to focal adhe-
sion sites underlying the extracellular matrix that particu-
larly contain integrins (Wang et al. 1993). In ﬁbroblasts,
clustering of integrins is followed by an increase in phos-
phorylation and recruitment of several other proteins to the
FAC, such as FAK and paxillin (Burridge et al. 1992;
Kornberg et al. 1992). For muscle tissue, the precise
mechanism that links FAK to the integrins is still unclear,
although it has been shown that FAK activation and the
expression of FAK and paxillin are increased in response to
mechanical loading (Fluck et al. 1999). FAK has also been
associated with increased translational signaling, either by
inducing Akt–mTOR signaling through PI3K (Xia et al.
2004) or by increasing p70S6K activation through mTOR,
independently of Akt (Klossner et al. 2009; Xia et al.
2004). In addition, SRF gene expression, which is both
mediated through FAK and the MAPKinases, induces both
a-actin and IGF-I expression and appears to be related to
hypertrophy in response to mechanical loading (Carson
et al. 1996; Charvet et al. 2006; Gineitis and Treisman
2001; Miano et al. 2007; Wei et al. 1998). FAK concen-
tration and its phosphorylation level, as well as paxillin,
integrin and SRF concentrations appear to be higher in the
high oxidative rat soleus compared to the low oxidative
plantaris muscle (Gordon et al. 2001). This suggests that
mechanical loading can induce a ﬁber type-speciﬁc
increase in protein synthesis that involves both FAK and
SRF signaling. However, the relative contribution of FAK
and PI3K in mechanical loading-induced activation of the
Akt–mTOR pathway remains elusive, as recently it has
been shown that mechanical loading can activate Akt–
mTOR independent of PI3K (Hornberger et al. 2007). In
addition, phospholipase D (PLD) and phosphatidic acid
(PA) provide another signaling mechanism to mTOR–
p70S6K independent of Akt (Fang et al. 2001; Hornberger
et al. 2006). Furthermore, the differential hypertrophic
effects of various types of mechanical loading via the
mTOR–p70S6K pathway may also depend on the nutri-
tional status, as it has been shown that muscle growth is
optimized by combining exercise and the ingestion of
amino acids and carbohydrates (Deldicque et al. 2005).
MAPKinases are also differentially expressed and acti-
vated in high and low oxidative ﬁbers in response to
stretch, contractile activity or metabolic stimuli (Csukly
et al. 2002; Wretman et al. 2000). p38 expression appears
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in phosphorylation in response to tetanic stimulation is
higher in the low oxidative EDL. For ERK and JNK
activities, there is no unambiguous information on ﬁber
type-speciﬁc expression in response to mechanical loading
(Csukly et al. 2002; Wretman et al. 2000). The ﬁber type-
speciﬁc role of the various MAPKinases is not clear,
mostly because of the lack of information on changes in
total and phosphorylated protein in response to mechanical
loading. Recently, inhibition of ERK in myotubes had been
shown to decrease their size and protein content, while
resistance exercise augmented both p38 and ERK1/2 and
p70S6K signaling. Furthermore, inhibition of all three
MAPK pathways induced NF-jB activity to a greater
extent in the rat soleus compared to the gastrocnemius
muscle in vivo (Deldicque et al. 2008; Shi et al. 2009). This
suggests that MAPK inhibition induces atrophy via NF-jB
in high oxidative muscle activity, but it is also likely that
inhibition of MAPKs are involved in atrophy in low oxi-
dative muscles via other stimuli and signaling pathways
that enhance protein degradation via the proteasome.
Downstream of Akt–mTOR, at the level of translation,
the initiation and elongation of translation of mRNA also
appears to be regulated by mechanical loading. In rats,
increased phosphorylation levels of eIF-2 as well as eIF-4
and its binding protein (4E-BP1) have been shown in
response to endurance exercise associated with a high
oxidative phenotype, whereas resistance training, dener-
vation or hind limb unloading, inducing a low oxidative
phenotype, de-phosphorylates these initiation factors
(Atheron et al. 2005; Hornberger et al. 2001; Thomson
et al. 2008). In response to an unloading period, con-
centrations of phosphorylated eEF-2 in rat soleus showed
a 50% decrease compared to those in control muscles,
while total eEF-2 remained unchanged. In EDL, no
effect was found for unloading on phosphorylated or
total amount of eEF-2 (Hornberger et al. 2001). These
results indicate that there may be a ﬁber type-speciﬁc
regulation in amount and activity of the initiation and
elongation factors in response to mechanical loading. In
addition, after resistance exercise in human vastus late-
ralis, p70S6K phosphorylation levels are signiﬁcantly
higher in type II ﬁbers (all isoforms) than in high oxi-
dative type I ﬁbers (Koopman et al. 2006). In rat EDL,
total p70S6K was sixfold higher compared to the soleus,
whereas the fraction of phosphorylated p70S6K was sub-
stantially lower in EDL [27% (EDL) vs. 64% (soleus)]
(Hornberger et al. 2001). These data suggest that the low
oxidative muscle ﬁbers have a larger potential to
phosphorylate p70S6K compared to high oxidative ﬁbers,
which has been related to increases in translation
initiation and subsequent gain in muscle mass (Baar and
Esser 1999).
Growth factors
Among the growth factors that have been discovered to
play a role in muscle adaptation, the key regulatory factors
are the insulin-like growth factor-I (IGF-I Ea and mechano-
growth factor, MGF) (Glass 2003; Goldspink 2005) and the
transforming growth factor-b (TGF-b) superfamily mem-
ber, myostatin (Lee and McPherron 2001; Zimmers et al.
2002). IGF-I is a potent stimulator of myoﬁbrillar protein
synthesis via the PI3K–Akt–mTOR pathway, the MAP-
Kinases and the calcineurin–PGC-1a pathway (Bodine
et al. 2001b; Haddad and Adams 2004; Semsarian et al.
1999) (Fig. 3). In vitro, IGF-I has been shown to activate
calcineurin and vice versa, which suggests that IGF-I acts
in a feed-forward loop with calcineurin, thereby promoting
gene expression associated with high oxidative metabolism
(Alﬁeri et al. 2007; Musaro et al. 1999; Semsarian et al.
1999). Furthermore, IGF-I Ea induces inﬂux of calcium
into the cytoplasm via L-type Ca
2? channels (Delbono
et al. 1997) (see ‘‘Intracellular calcium’’) and is involved in
recruitment of satellite cells, either independently or in
combination with other growth factors such as basic
ﬁbroblast growth factor (bFGF) or hepatocyte growth
factor (HGF) and MGF (Allen and Boxhorn 1989; Doumit
et al. 1993; Yang and Goldspink 2002). In addition, IGF-I
also acts as an inhibitor of degradation via inhibition of the
FOXO–E3 ligase–proteasome and attenuating caspases-
mediated apoptosis (Bodine et al. 2001b; Dalla Libera et al.
2004). These results suggest that IGF-I signaling is
important for mediating increases in the capacity for pro-
tein accumulation in response to mechanical loading.
However, it appears that other routes besides IGF-I/insulin
signaling may also contribute to mechanical load-induced
hypertrophy, as it has been shown that hypertrophy is
possible without a functional insulin-like growth factor
receptor (Spangenburg et al. 2008). These and other studies
indicate that the debate on whether IGF-I signaling or other
mechanical load-induced routes are the major regulators of
increasing ﬁber size has not been settled yet (Stewart et al.
2009).
Myostatin is a negative regulator of muscle size as it
stimulates the expression of the FOXO–E3 ligase–protea-
some system and inhibits proliferation of satellite cells
(McCroskery et al. 2003; McFarlane et al. 2006) (Fig. 3).
Myostatin activates FOXO1, while FOXO1 in turn
increases myostatin expression, resulting in a feed-forward
loop between myostatin and FOXO and a subsequent
increase in protein degradation (Allen and Unterman
2007). In addition, FOXO1 also inhibits IGF-1-mediated
satellite cell proliferation (Machida and Booth 2004).
However, it has been shown that myostatin over-expression
in rat tibialis anterior muscle was unable to alter the
activity of proteasome components, and treatment of
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in a decrease in the expression of E3 ligases (Amirouche
et al. 2008; Trendelenburg et al. 2009). Instead, myostatin
was suggested to negatively regulate protein synthesis by
inhibition of the Akt–mTOR pathway through inhibition of
Akt phosphorylation via phosphorylation of Smad2 and
Smad3, and by down-regulating calcineurin signaling as
well as the transcription factors MyoD and myogenin
(Amirouche et al. 2008; McFarlane et al. 2006; Michel
et al. 2007). IGF-I has been shown to block the effects of
myostatin on Akt when applied to myoblasts or myotubes,
suggesting that IGF-I/Akt signaling is dominant over
myostatin-induced activation of Akt (Trendelenburg et al.
2009). Although the actions of myostatin are yet to be
completely understood, these data indicate that myostatin
negatively regulates muscle size by decreasing Akt-
induced protein synthesis as well as by stimulating protein
degradation via a FOXO-dependent mechanism. Whether
myostatin also affects functional characteristics such as
force generation is still under debate (Amthor et al. 2007;
Mendias et al. 2006).
Mechanical loading has been shown to up-regulate the
expression of different IGF-I isoforms up to 15-fold either
alone or in combination with sustained electrical stimula-
tion (Heinemeier et al. 2007; McKoy et al. 1999). In
contrast, myostatin expression decreased two- to eightfold
in response to different types of contractile activity, the
effect being largest during eccentric contractions (Hei-
nemeier et al. 2007). This suggests that mechanical loading
is an important stimulus for regulating ﬁber size, which is
mediated through increased expression of IGF-I combined
with down-regulation of myostatin. New experimental
PCR data in this paper show that, when normalized to total
RNA, IGF-I mRNA expression levels showed no differ-
ences between high oxidative rat soleus and low oxidative
EDL muscles. In contrast, mean myostatin expression
levels were 6.5-fold higher in the EDL (Fig. 4a). Because
the soleus contains 2.3-fold more total RNA compared to
EDL (Fig. 2a), we also normalized IGF-I and myostatin
mRNA expression relative to muscle mass. After normal-
izing in this way, IGF-I mRNA levels were 2.5-fold higher
in soleus compared to EDL, whereas myostatin mRNA
levels were 2.8-fold higher in the EDL (Fig. 4b). The latter
result supports the data of others showing that myostatin,
myostatin receptor and FOXO1 mRNA levels were higher
in low oxidative muscle ﬁbers (Allen and Unterman 2007;
Atherton et al. 2004; Carlson et al. 1999). These data
indicate that IGF-I expression is higher in high oxidative
ﬁbers, whereas myostatin and FOXO levels are relatively
high in low oxidative ﬁbers.
In addition to mechanical loading-induced expression of
local factors, several other components such as albumin,
IGF-binding proteins, receptors, cytokines (i.e., TNF-1a,
IL-1 and IL-6), calcium and vitamins may modulate the
effects of IGF-I and myostatin (Casse et al. 2003; Clem-
mons 1998; Coletti et al. 2005; Jaspers et al. 2008; Ling
et al. 1997; Pfeifer et al. 2002). For example, insulin
receptor phosphorylation, insulin receptor substrate (IRS-2)
phosphorylation, as well as the downstream PI3K activity
were all shown to be signiﬁcantly higher in the high
oxidative soleus compared to EDL (Song et al. 1999). As
IGF-I also binds the insulin receptor (Shimizu et al. 1986)
and IGF-I expression is higher in high oxidative ﬁbers
(Fig. 4b), these results conﬁrm the greater IGF-I binding
capacity in high oxidative ﬁbers. These results indicate
relatively high expression levels of IGF-I mRNA, its
Fig. 4 Differences in mRNA concentrations of insulin-like growth
factor-I (IGF-1, all isoforms) and myostatin in rat soleus (SO) and
extensor digitorum longus (EDL) muscles (n = 6) (for methods see
supplementary section I). a mRNA normalized to total RNA relative
to EDL. No differences between SO and EDL were found for IGF-1,
but myostatin mRNA was 6.5-fold lower in SO (p\0.001). b mRNA
normalized to muscle tissue weight relative to EDL. IGF-1 expression
was 2.5-fold higher in SO, whereas myostatin was 2.8-fold lower in
SO (p\0.002). Asterisks indicate signiﬁcant difference compared to
EDL
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oxidative muscle ﬁbers, while myostatin expression is low
in these ﬁber types. Whether these differential expression
levels implicate related local effects on the producing
muscle ﬁber remains to be determined. Very little is known
about the concentrations and activity of growth factors in
the vicinity of the sarcolemma. Do the growth factors
diffuse and is there a gradient from one ﬁber to the other?
With what afﬁnity do growth factors bind to their receptors
or binding proteins that enhance or attenuate their func-
tion? There are indications that growth factors bind to the
glycosaminoglycans in the heparan sulfates, which may
facilitate their activity at their receptor (Roghani et al.
1994). As the growth factors may also have paracrine
effects, the higher IGF-I expression in high oxidative ﬁbers
may affect high oxidative and also neighboring low oxi-
dative ﬁbers. The magnitude of autocrine and paracrine
effects warrants further research. Information is required
on expression and activity of the growth factors such as
IGF-I and myostatin, as well as on the expression levels of
their receptors (IGF-IR and activin receptors), smad pro-
teins and the inhibitory binding proteins (e.g., IGFBP-4,
follistatin, myostatin propetide), which may enhance or
attenuate the function of these growth factors.
Cytokines
Several cytokines have been reported to play a role in
muscle adaptation. Interleukin (IL)-6 is released in muscle
tissue in response to sustained exercise and contributes to
increased AMPK and calcineurin activity and subsequent
high oxidative gene expression (Banzet et al. 2005)
(Fig. 3). IL-6 also has been reported to stimulate satellite
cell proliferation (Austin and Burgess 1991). In contrast,
tumor necrosis factor (TNF)-a, IL-1a and IL-1b promote
muscle catabolism (Flores et al. 1989; Zamir et al. 1993).
TNF-a stimulates the expression of the ubiquitin-ligase
MAFbx via p38 and both TNF-a and IL-1 induce increased
ROS production, activation of the NF-jB pathway and
subsequent protein loss (Jackman and Kandarian 2004;
Li et al. 2005) (Fig. 3). In addition, TNF-a increases
myonuclear apoptosis in myotubes and in mouse skeletal
muscle, TNF-a appears to inhibit muscle regeneration by
inhibiting embryonic MyHC expression (Coletti et al.
2005; Vescovo and Dalla Libera 2006).
In human skeletal muscle, IL-6 expression is relatively
high in the high oxidative ﬁbers (Plomgaard et al. 2005).
Although no ﬁber type-speciﬁc expression of TNF-a was
found in young rats, TNF-a expression increased more with
age in the low oxidative rat vastus lateralis muscle com-
pared to the high oxidative soleus. This suggests a ﬁber
type-dependent regulation of TNF-a with age (Phillips and
Leeuwenburgh 2005). Based on the reported differences in
ﬁber type-speciﬁc expression of cytokines, and the poten-
tial role that cytokines play in regulating protein turnover,
it is tempting to speculate that cytokines play a role in
regulating the ﬁber type-speciﬁc differences in protein
turnover. This assumes that ﬁber type-speciﬁc differences
in protein turnover exist and can be demonstrated
experimentally.
Intracellular calcium
Intracellular calcium concentrations are increased by
stimuli such as action potentials, stretch and/or hypoxia
(Allen et al. 2005; Eltit et al. 2004; Powers et al. 2007),
which release calcium from intracellular stores (sarco-
plasmatic reticulum), or by growth factor signaling (e.g.
IGF-I, see above). Rises in [Ca
2?]i trigger several pro-
cesses involved in ﬁber type-speciﬁc gene expression
(Fig. 3). [Ca
2?]i induces transcriptional activation through
the calcineurin/CaMK pathways, the MAPK pathways and
increased expression of transcription factors c-fos and c-
jun, which are members of the immediate early gene family
transiently and rapidly activated in many processes ranging
from differentiation and cell growth to hypertrophy
(Carrasco et al. 2003; Chin et al. 1998; Ruwhof and van der
Laarse 2000). In addition, it has also been suggested that
the Akt–mTOR pathway is sensitive to [Ca
2?]i. Whether
this effect of calcium is mediated by mechanical loading or
IGF-I is unclear. Several mechanisms are known via which
calcium could affect the Akt–mTOR signaling pathway,
including vacuolar protein sorting mutant 34 (Vps34) and
amino acid exposure (Gulati et al. 2008; MacKenzie et al.
2009). Furthermore, calcium/calcineurin-induced IGF-I
expression provides another potential link to Akt–mTOR
via PI3K (Alﬁeri et al. 2007). Protein degradation is also
partly controlled by [Ca
2?]i as it increases the activity of
Ca
2?-mediated proteases and the proteasome system
(Powers et al. 2007). Although the regulation of [Ca
2?]i in
heart and skeletal muscle is complex, levels of resting
[Ca
2?]i appear to be higher in high oxidative ﬁbers (Batkai
et al. 1999). This suggests that calcium-induced protein
synthesis and degradation are higher in high compared to
low oxidative ﬁbers.
Collectively, mechanical stimuli are important regula-
tors of muscle mass, although the mechanisms connecting
the mechanical events onto the intracellular signaling
structure are complex and warrant further investigation. It
may well be that the onset of mechanical load induces both
acute and delayed signals regulating protein synthesis and
degradation. For example, the acute onset of mechanical
loading induces signiﬁcant and immediate increases in Akt
phosphorylation, which returns to baseline within 3 h after
cessation of the load (Nader and Esser 2001). Such acute
effects in response to mechanical loading may be mediated
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2?-mediated signaling, Vps34 and/or
PLD. In humans IGF-I mRNA expression is up-regulated
2.5 h after a single bout of resistance exercise and persists
for 2 days, suggesting that growth factors comprise a
mechanism involved in the delayed onset of signaling
pathways that control protein synthesis (Greig et al. 2006).
Resistance exercise resulted in an immediate (1–4 h) and
concurrent up-regulation of markers involved in protein
synthesis (mTOR, p70S6K) and protein degradation
(MuRF, but not MAFbx) in human muscles (Louis et al.
2007; Mascher et al. 2008). However, the acute response
was followed by a delayed ([8 h) decrease in markers for
degradation, whereas the markers for protein synthesis
were stable (Louis et al. 2007; Mascher et al. 2008). Also,
after a longer period of resistance exercise, it was shown
that down-regulation of proteolytic markers persisted,
whereas synthetic markers were similar compared to pre-
exercise (Mascher et al. 2008; Zanchi et al. 2009). In
contrast, endurance exercise in humans increased the pro-
teolytic factors MAFbx, MuRF and FOXO directly (1–4 h
after exercise), while long-term effects were unclear (Louis
et al. 2007). It appears that different exercise protocols
result in the selective activation of speciﬁc intracellular
signaling pathways, which are most likely responsible for a
concurrent training effect (see above). It remains to be
determined in what way the acute or delayed onset of
signaling pathways in response to mechanical load affect
the balance between protein synthesis and degradation, and
whether such responses are ﬁber-type speciﬁc.
Cellular energy status
The availability of cellular energy (DGATP) is predomi-
nantly maintained by mitochondria. It is generally assumed
that the ratio between AMP and ATP (AMP:ATP) reﬂects
the energy status of a muscle cell and acts as a major
stimulus for AMPK (Hardie and Sakamoto 2006). An
increase in AMP:ATP (e.g., caused by contractile activity
or hypoxia) leads to robust activation of AMPK, which
attenuates the translational signaling, while at the same
time gene expression associated with high oxidative
metabolism and mitochondrial biogenesis are enhanced
and NF-jB–proteasome-mediated degradation is increased
(Fig. 3).
In general, mitochondrial proteins turn over with a half-
life between 4 and 8 days with half-life being shortest in
the high oxidative ﬁbers, although turnover of cytochrome
c was higher in the low oxidative ﬁbers (Booth and Hol-
loszy 1977; Hickson and Rosenkoetter 1981; Terjung 1979;
Wicks and Hood 1991). Based on these data, it may be
speculated that a continuous stimulus for AMPK activation
is required to maintain mitochondrial content at an elevated
level; otherwise, a loss of oxidative capacity will result.
Low cellular energy levels, which are generally induced in
response to sustained contractile activity or hypoxia, will
activate AMPK. As AMPK simultaneously reduces trans-
lational processes while increasing high oxidative gene
expression and the rate of protein degradation, a low
energy status would be associated with a high rate of
protein turnover that limits the potential to increase ﬁber
size.
Cellular oxygen levels
Assuming that the half saturation pressure of myoglobin is
2.75 mmHg (Rossi-Fanelli and Antonini 1958) and 90% of
myoglobin is oxygenated at rest (Richardson et al. 2006), it
can be estimated that the average muscle ﬁber PO2 in
humans equals 25 mmHg at rest. As mentioned above, an
interstitial oxygen tension of about 14 mmHg is required to
prevent anoxic cores (and impaired mitochondrial respira-
tion) at the maximum rate of oxygen consumption.
Therefore, cellular oxygen levels play a critical role in
regulating muscle protein turnover (see oxidative stress-
mediated proteolysis, Suppl. Fig. 2D, Fig. 3). Hypoxia
increases ROS production and affects mitochondrial oxy-
gen uptake and permeability, which reduces cellular ATP
production and activates AMPK. In myotubes, in response
to hypoxia, the rate of protein degradation was elevated
and the rate of protein synthesis reduced, explaining the
atrophic effects of hypoxia (Caron et al. 2009).
The effects of hypoxia on ﬁber size are at least in part
mediated via ROS production, which is likely to exceed
antioxidant production during prolonged periods of
hypoxia, resulting in an elevated rate of protein degrada-
tion (Powers et al. 1999). High oxidative ﬁbers generally
consume more oxygen compared to low oxidative ﬁbers
and therefore it is assumed that their rates of ROS and
antioxidant production are relatively high compared to low
oxidative ﬁbers (Malinska et al. 2009; Powers et al. 1999).
Because ROS are scavenged by antioxidants, this does not
necessarily imply that the ROS concentrations differ
between ﬁber types, although there are indications that
speciﬁc types of radicals may vary between high and low
oxidative ﬁbers (Anderson and Neufer 2006). The speciﬁc
function of free radicals may also differ between ﬁber
types. An example of this is nitric oxide (NO), a relatively
well-studied free radical in muscle. NO is produced by
various NO synthase isoforms (NOS), such as neuronal
NOS (nNOS) and endothelial NOS (eNOS), which are
permanently expressed in skeletal muscle. The data on
NOS are conﬂicting. For example in humans, nNOS pro-
tein levels are similar between ﬁber types, but increase in
all ﬁber types in response to exercise (McConell et al.
2007). Also, higher as well as lower concentrations of
nNOS have been reported in high oxidative ﬁbers,
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Kobzik et al. 1994). In addition, the production of NO not
only depends on expression levels of NOS, but also on the
activity of different isoforms, which can be modulated by
calcium and calmodulin (Nathan and Xie 1994). In
cachectic mice, muscle NO production and subsequent
activation of antioxidant genes were higher in high oxi-
dative muscle ﬁbers, thereby protecting these ﬁbers against
muscle wasting (Yu et al. 2008). This suggests that NO
leads to increased ROS scavenging and plays a protective
role by inhibiting expression of E3 ligases and protein
degradation. In addition, NO plays a role in mitochondrial
biogenesis as well as in preventing exercise-related mem-
brane damage and breakdown of structural muscle protein,
while in myoblasts NO inhibits calpain-mediated proteol-
ysis of cytoskeletal proteins (Koh and Tidball 1999;
Nguyen and Tidball 2003; Nisoli et al. 2003). However,
NO can also react with superoxide anion to produce the
highly toxic peroxynitrite, which is associated with
enhanced protein degradation and apoptosis (Ghafourifar
and Cadenas 2005). These data show that the role of free
radicals, such as NO, in regulating protein turnover
remains ambiguous, despite ﬁber type-speciﬁc differences
in concentration.
Cellular oxygen supply can be improved by increasing
capillarization, hematocrit or myoglobin concentration
(Des Tombe et al. 2002; van Beek-Harmsen et al. 2004).
The signal transduction mechanisms that regulate oxygen
supply have been shown to involve the hypoxia-inducible
factor-1 (HIF-1a), which mediates expression of erythro-
poietin and angiogenic growth factors such as vascular
endothelial growth factor (VEGF) (Hirota and Semenza
2006). VEGF up-regulates myoglobin in vivo and in vitro
and as a result HIF-1a also improves tissue oxygenation
in the absence of improved vascularization (Hirota and
Semenza 2006; van Weel et al. 2004). In addition, hypoxia-
induced calcium transients have been shown to induce
myoglobin expression in mice (Kanatous et al. 2009).
Besides facilitation of oxygen transport, oxyhemoglobin
and myoglobin act as scavengers for NO (Brandish et al.
1998; Flogel et al. 2001). There is some debate on whether
oxyhemoglobin and myoglobin can reduce NO levels
partially or completely in vivo (Hazarika et al. 2008;
Kreutzer and Jue 2004). However, since NO increases ROS
scavenging and subsequent proteasome activity (Yu et al.
2008), it may be hypothesized that a higher oxyhemoglo-
bin/myoglobin concentration is linked to an increased
ROS-mediated protein degradation. If so, increasing myo-
globin may increase the oxidative capacity, but it also
stimulates protein degradation, which limits the ﬁber size
at a constant rate of protein synthesis.
Alternative strategies for improving oxygen supply
may include alteration of mitochondrial distribution, for
example by relocating the mitochondria to the sarcolemma
(Hardy et al. 2009). However, a predominantly subsarco-
lemmal distribution is associated with large intracellular
diffusion distances for metabolites, which would have
functional consequences (Kinsey et al. 2007) and may also
be associated with pathological features such as muscle
weakness and hypotonia (Reid and MacGowan 1998).
In conclusion, hypoxia results in elevated ROS levels
and reduced cellular ATP levels, concomitant with an
increased degradation and decreased synthesis of muscle
protein. Although both ROS and antioxidant production
differ between ﬁber types, the cumulative and relative
effects of various ROS concentrations on the regulation of
protein turnover in different ﬁber types are not clear yet.
However, it appears that ROS do play a role in hypoxia-
induced reduction in ﬁber size. In addition, it is likely that
hypoxia affects ﬁber size via other ﬁber type-speciﬁc
mechanisms that are induced by the low cellular energy
status during hypoxia.
Conclusions
Ever since the classical training experiments of Hickson
(1980), we know that human skeletal muscles have limited
capacity to improve strength and fatigue resistance at the
same time. This observation is valid for striated muscle
tissue, in general, as an inverse relationship exists between
muscle ﬁber size and its oxidative capacity (Fig. 1). This
relationship suggests that striated muscle cells are evolved
in such a way that anoxic cores are prevented. The central
question addressed in this review is: ‘why do the high
oxidative ﬁbers remain small compared to the low oxida-
tive ﬁbers’?
At ﬁrst sight it appears paradoxical that high oxidative
ﬁbers are relatively small, since these ﬁbers have a larger
capacity for protein synthesis compared to low oxidative
ﬁbers. All major components of the transcription machin-
ery (i.e., satellite cells, myonuclei, mitochondria and
mRNA) as well as total ribosomal RNA content are present
in higher quantities in high oxidative ﬁbers. This paradox
may not be a quantitative one, as there is a discrepancy in
mass of large myoﬁbrillar proteins and much smaller oxi-
dative proteins. However, another paradoxical outcome of
this review is that IGF-I expression, a potent stimulator of
myoﬁbrillar protein synthesis and hypertrophy (Bodine
et al. 2001b; Stitt et al. 2004), is also higher in high oxi-
dative muscles, whereas myostatin, an endogenous inhibi-
tor of muscle mass (Lee and McPherron 2001; Zimmers
et al. 2002), shows higher expression in low oxidative
muscles (Fig. 4).
Several critical stimuli, such as contractile activity,
mechanical loading, cellular energy levels and hypoxia,
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123control the activity status of signaling pathways involved in
regulating ﬁber size in high and low oxidative ﬁbers
(Fig. 3). The rate of synthesis is largely regulated by the
Akt–mTOR pathway, which induces hypertrophy in
response to short contractions, mechanical loading and
regulation and presence or absence of growth factors such
as IGF-I and myostatin, respectively. In contrast, hypoxia
and sustained contractile activity, associated with low
cellular energy levels, activate Ca
2?-calcineurin and
AMPK. Both calcineurin and AMPK stimulate oxidative
metabolism and slow-type gene expression through PGC-
1a, while AMPK simultaneously attenuates protein syn-
thesis by inhibiting mTOR, via activation of TSC-2. Akt
activation has been shown to restore cellular energy levels
via an increase in glycolysis and oxidative phosphoryla-
tion, thereby inactivating AMPK (Gottlob et al. 2001;
Hahn-Windgassen et al. 2005). Therefore, the competitive
interaction between Akt–mTOR and AMPK acts as a
‘switch’ that controls the synthesis of myoﬁbrillar protein
and metabolic protein (Fig. 3) (Atheron et al. 2005; Baar
2006). It has been shown that activation of TSC-2 by
AMPK is dominant over Akt-induced inactivation of TSC-
2 and leads to inactivation of mTOR (Inoki et al. 2003).
This implies that the cellular energy status may be crucial
in mediating either a low oxidative phenotype and a large
size or a high oxidative phenotype and a small size.
However, currently we do not know whether the ‘Akt–
AMPK switch’ is sufﬁcient to explain why high oxidative
ﬁbers show such limited hypertrophy, largely because
mTOR can be activated independently of Akt and mTOR
also appears to be required for the regulation of oxidative
metabolism (Bentzinger et al. 2008; Cunningham et al.
2007; Fang et al. 2001; Hornberger et al. 2006). In addi-
tion, recent experiments on humans showed that, for
example, training history and nutritional status (amino acid
and carbohydrate ingestion) inﬂuence the molecular
response to different types of contractile activity (resis-
tance vs. endurance) (Coffey et al. 2006; Deldicque et al.
2008). To link various stimuli to the regulation of ﬁber
size, one needs to know the relative contribution of each
pathway involved in myoﬁbrillar protein synthesis and
mitochondrial biogenesis in different ﬁber types. The
canonical Akt/mTOR–AMPK switch is merely a mecha-
nism controlling the synthesis of myoﬁbrillar and oxidative
protein and may therefore only partly explain the relatively
small size of the high oxidative ﬁbers. As the balance
between synthesis and degradation determines whether
protein is gained or lost, the rate of protein degradation also
largely contributes to regulating the ﬁber size.
Despite the still limited information regarding the reg-
ulation of protein degradation in different ﬁber types,
experimental data in this paper show that several compo-
nents of the degradation machinery (i.e., expression levels
of ubiquitin-ligases MAFbx and MuRF, Fig. 2) are about
twofold higher in high oxidative ﬁbers. These data support
the hypothesis that the high rate of protein degradation in
high oxidative ﬁbers is balanced by a high rate of synthesis,
thereby creating a steady state protein turnover. However,
if the rate of degradation becomes higher (e.g., due to low
energy status or high ROS production), such as that in the
more oxidative ﬁbers, this would require an increasingly
high rate of synthesis to maintain the steady state. There-
fore, the relatively high rate of degradation in high oxi-
dative ﬁbers may be an important factor limiting the size of
these ﬁbers.
The rate of protein degradation is at least in part regu-
lated by growth factor signaling. IGF-I and myostatin
concentrations are differentially regulated in high and low
oxidative ﬁbers (Fig. 4), and in response to contractile
activity their actions both have a hypertrophic effect. IGF-I
stimulates, whereas myostatin inhibits, Akt (Fig. 3);
therefore, it can be expected that phosphorylated Akt levels
are higher in high oxidative ﬁbers. The single study
reporting on total and phosphorylated Akt concentrations
in high and low oxidative muscles conﬁrmed that both total
and phosphorylated Akt were higher in the high oxidative
soleus compared to the low oxidative EDL (Sakamoto et al.
2002). However, Akt phosphorylates FOXO, resulting in
translocation of FOXO out of the nucleus and a decreased
transcription of FOXO target genes, MAFbx and MuRF.
Although there are no quantitative data available on total
and phosphorylated FOXO protein concentrations, FOXO
mRNA was shown to be higher in low oxidative muscles,
when normalized to b-actin (Allen and Unterman 2007).
Our data show that high oxidative soleus muscle contains
two times more total RNA per microgram muscle tissue
compared to the low oxidative EDL (Fig. 2a). We have
shown that when normalized per muscle tissue weight,
EDL shows twofold higher myostatin expression (Fig. 4b),
indicating that myostatin mRNA is higher in low oxidative
ﬁbers. Myostatin has been shown to induce expression and
nuclear accumulation of FOXO (McFarlane et al. 2006). As
FOXO binds and activates the myostatin promoter, it
functions in a feed-forward loop with myostatin (Allen and
Unterman 2007). These data suggest that myostatin and
nuclear FOXO concentrations are higher in the low oxi-
dative ﬁbers. As nuclear localization of FOXO enhances
the expression of MAFbx and MuRF (Sandri et al. 2004),
higher expression levels of these E3 ligases are expected in
low oxidative ﬁbers. We found that when normalized to
total RNA, MAFbx and MuRF expression were similar in
soleus and EDL muscles (Fig. 2b). However, as the soleus
contains about twofold more total RNA compared to EDL,
normalizing relative to muscle tissue weight showed that
MAFbx and MuRF expression were both about twofold
higher in the soleus (Fig. 2c). This indicates that the higher
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due to other signaling routes besides FOXO. The most
likely candidates for such alternative routes are the
AMPK–NF-jB pathway and the p38 MAPK–NF-jB
pathway (Fig. 3). The relatively high levels of NF-jB
expression in high oxidative muscles (Atherton et al. 2004;
Phillips and Leeuwenburgh 2005) combined with higher
expression levels of MAFbx and MuRF in high oxidative
muscles (Fig. 2) support this hypothesis.
Considerable progress has been made in elucidating
the signaling mechanisms and their interactions that
control protein synthesis and degradation in skeletal
muscle. In Fig. 5, these interactions are integrated into a
model for the regulation of ﬁber size and oxidative
metabolism. In general, sustained low-intensity activity
results in a reduced cellular energy status (AMP:ATP),
hypoxia, elevated [Ca
2?]i and increased IGF-I expres-
sion, whereas short bursts of activity and at high-inten-
sity mechanical loads induce transient changes in [Ca
2?]i
and increased expression of growth factors. These types
of contractile activity will induce ﬁber type-speciﬁc
signaling pathways that enhance the rates of protein
synthesis and degradation, or both. The relative
concentrations of structural muscle proteins or metabolic
proteins largely depend on the interaction between
pathways at the ‘Akt/mTOR–AMPK switch’ (Atheron
et al. 2005; Baar 2006). In addition, the regulation of
cellular oxygen and energy levels determine the impact
of protein degradation on the rate of turnover. Conditions
of hypoxia and low energy status induce ROS- and
AMPK-mediated NF-jB activity. The subsequent
increase in the rate of myoﬁbrillar degradation limits
ﬁber size, which facilitates the restoration of cellular
energy status and oxygen tension and prevents hypoxia.
In contrast, restoration of cellar energy levels attenuates
AMPK activation and subsequently the rate of protein
degradation and the capacity to sustain mitochondrial
biogenesis and oxidative metabolism via AMPK–PGC1a.
However, the oxidative metabolism is also increased by
activation of mTOR, which has been related to the sig-
niﬁcant amounts of energy required for anabolic actions
such as protein synthesis (Cunningham et al. 2007).
Therefore, it appears that hypoxia and low cellular
energy levels reduce the synthesis, while simultaneously
increasing the degradation of muscle protein. In contrast,
normoxic conditions and high cellular energy levels
Fig. 5 Schematic diagram representing the regulation of muscle ﬁber
size and oxidative metabolism. The type of contractile activity,
ranging from sustained low-level activity to short high-level activity,
combined with the cellular energy (AMP:ATP) and oxygen (ROS
concentration) status determine the rate of synthesis and degradation
of both contractile and metabolic protein. The balance between
synthesis and degradation reﬂects the rate of protein turnover and
determines whether contractile or metabolic protein is gained or lost,
thereby regulating the ﬁber size. Solid lines are dominant processes in
high oxidative ﬁbers, whereas dashed lines are dominant in low
oxidative ﬁbers. The plus and minus signs reﬂect the effects of the
different processes (e.g., synthesis, degradation, hypoxia) on ﬁber size
and mitochondrial density (for details see text)
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thesis and by limiting the rate of degradation.
Currently, we are beginning to understand how different
types of contractile activity and mechanical loading inter-
act and affect the activation of pathways involved in pro-
tein synthesis and degradation. However, the relative
contribution of the pathways in high and low oxidative
ﬁbers, the effect of nutritional status (e.g., amino acids and
carbohydrates) and also the time frames of the responses
that convert mechanical events at the sarcolemma onto the
intracellular signaling structure are still poorly understood.
In addition, it should be realized that an increase in muscle
mRNA in response to activity or mechanical load does not
necessarily induce‘ a higher protein production. The rela-
tionship between mRNA variation and protein synthesis
should be determined systematically in response to various
types of activity and mechanical loading: because it
appears that timing of both the synthetic and proteolytic
response are differently regulated, depending on the type of
exercise and duration (Jensen et al. 2009). With this in
mind, several potential mechanisms may account for the
differences in up-regulation of gene and protein expression
involved in the hypertrophic response that need to be
conﬁrmed. Growth factors show a delayed induction in
response to changes in mechanical loading, whereas
growth factor-independent mechanisms, such as signaling
via integrin-FAK, Ca
2?, amino acids, Vps34 and/or PLD,
may be responsible for the early induction of protein syn-
thesis. In our view, the potential mechanisms that can have
a major effect on the ﬁber type-speciﬁc regulation of pro-
teolytic factors in response to various types of exercise
comprise the AMPK–NF-jB pathway, the p38 MAPK–
NF-jB pathway and the Ca
2?-mediated proteasome path-
way. Understanding the ﬁber type and timing-related dif-
ferences in protein synthesis and degradation requires an
integrative approach, combining in vitro in situ as well as
in vivo studies. Quantitative ﬁber type differentiating
approaches obtain insight into interactions between path-
ways and the integrated effects of different loading pro-
grams and stimuli. For example, ex vivo culture systems of
mature muscle ﬁbers (Jaspers 2004; Jaspers et al. 2008) are
well deﬁned and can be used for controlled manipulation of
growth factors, mechanical loading and oxygen tension,
either independently or in combination. Such approaches
may uncover interactions between signal transduction
routes, which are to be veriﬁed in vivo. Furthermore, to
assess ﬁber type-speciﬁc absolute total and phosphorylated
concentrations of the major signaling molecules involved
in muscle protein turnover, quantitative immunohistologi-
cal methods or in situ hybridizations (van Beek-Harmsen
et al. 2004; van Beek-Harmsen and van der Laarse 2005)
are required. These methods allow the identiﬁcation of the
activity status of pathways inducing a high or low oxidative
phenotype and clarify the impact of the pathways and
stimuli on the muscle ﬁber size.
Perspectives and signiﬁcance
It is a challenge to optimize training and rehabilitation
programs with respect to the functional demands. To
design the appropriate training and rehabilitation strate-
gies, one needs to understand the interactions between
signaling pathways for myoﬁbrillar protein synthesis,
mitochondrial biosynthesis and degradation. Understand-
ing in what way oxygen supply (in terms of increased
capillarization, hematocrit and expression of myoglobin)
can be improved without compromising the capacity for
force production is another challenge. For instance, when
both high peak power and high steady state power are
required, such as in the ﬁnal sprint of a cycling stage or a
marathon, one would need to design a training strategy
inducing large ﬁbers with high capacity for oxygen
transport to sustain a high steady state power, as well as
large glycogen stores to maintain a high anaerobic power
during the sprint. To maintain a certain size, cellular
oxygen tension and ROS must be kept within a critical
range of beneﬁcial concentrations and cellular energy
levels may not be reduced. A small disturbance in oxygen
or energy levels, either up or downward, by contractile
activity or hypertrophy, will result in adaptation of the
ﬁber size and the oxidative metabolism. Whether a mus-
cle ﬁber is actually capable of increasing its size and
becoming stronger while maintaining endurance capacity
depends primarily on: (1) the application of appropriate
stimuli (i.e., sustained contractile activity combined with
short, powerful mechanical loading) and availability of
the machinery and essential substrates (e.g., amino acids)
to maintain the rate of muscle protein synthesis; (2) the
capacity to increase oxygen transport (e.g., by improving
heart and lung function or angiogenesis, hematocrit and
myoglobin); and (3) prevention of tissue hypoxia and
chronically reduced cellular energy status. For patients
suffering from chronic diseases, such as heart failure and
COPD, or for sportsmen and women exploring their
physical limits, it implies that one must know the status
of the above-mentioned determinants to develop an
appropriate strategy to improve their performance.
Furthermore, quantitative information and sophisticated
mathematical models are required to predict the outcome
of manipulations of interacting signal transduction routes.
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